<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE book-part-wrapper PUBLIC "-//NLM//DTD BITS Book Interchange DTD v2.0 20151225//EN" "http://jats.nlm.nih.gov/extensions/bits/2.0/BITS-book2.dtd">
<book-part-wrapper id="article-67758" content-type="chapter" dtd-version="2.0">
  <book-meta>
    <book-id book-id-type="pmcid">statpearls</book-id>
    <book-title-group>
      <book-title>StatPearls</book-title>
    </book-title-group>
    <pub-date publication-format="electronic" date-type="pubr">
      <month>01</month>
      <year>2024</year>
    </pub-date>
    <publisher>
      <publisher-name>StatPearls Publishing</publisher-name>
      <publisher-loc>Treasure Island (FL)</publisher-loc>
    </publisher>
    <permissions>
      <copyright-statement>Copyright &#x000a9; 2024, StatPearls Publishing LLC</copyright-statement>
      <license xmlns:xlink="http://www.w3.org/1999/xlink" license-type="open-access" xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/">
        <license-p>
This book is distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0)
(<ext-link xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/" ext-link-type="uri">
http://creativecommons.org/licenses/by-nc-nd/4.0/
</ext-link>), which permits others to distribute the work, provided that the article is not altered or used commercially. You are not required to obtain permission to distribute this article, provided that you credit the author and journal.
</license-p>
      </license>
    </permissions>
    <custom-meta-group>
      <custom-meta>
        <meta-name>books-source-type</meta-name>
        <meta-value>Database</meta-value>
      </custom-meta>
    </custom-meta-group>
    <notes notes-type="disclaimer">
      <p>The intent of StatPearls review books and articles is to identify knowledge deficits and assist you in the learning process. Review books and articles are not intended to be a source of the knowledge base of medicine. The authors and editors do not warrant the information is complete or accurate. The reader is encouraged to verify content and questions in several references. All drug indications and dosages should be verified before administration.</p>
      <p>The authors and editors would like to extend special thanks to Erin Hughes and Gerson Rubio for their editorial support.</p>
    </notes>
  </book-meta>
  <book-part book-part-type="chapter">
    <book-part-meta>
      <title-group>
        <title>Liver Imaging</title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Azizaddini</surname>
            <given-names>Shahrzad</given-names>
          </name>
          <aff>Aventura Hospital and Medical Center</aff>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Mani</surname>
            <given-names>Nisha</given-names>
          </name>
          <aff>FIU / Aventura Medical Center</aff>
        </contrib>
      </contrib-group>
      <author-notes>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Shahrzad Azizaddini declares no relevant financial relationships with ineligible companies.</p>
        </fn>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Nisha Mani declares no relevant financial relationships with ineligible companies.</p>
        </fn>
      </author-notes>
      <pub-history>
        <date date-type="updated">
          <day>20</day>
          <month>2</month>
          <year>2023</year>
        </date>
      </pub-history>
    </book-part-meta>
    <body>
      <sec id="article-67758.s1" sec-type="Continuing Education Activity">
        <title>Continuing Education Activity</title>
        <p>Liver lesions have a broad spectrum of pathologies, ranging from benign lesions such as hemangiomas to malignant lesions such as primary hepatocellular carcinoma and metastasis. Imaging is a crucial step in diagnosing these conditions, as liver enzymes can be elevated in 9% of people in the U.S. This activity will review liver imaging for an interprofessional team.</p>
        <p>
<bold>Objectives:</bold>
<list list-type="bullet"><list-item><p>Identify&#x000a0;the options for liver imaging with an emphasis on CT and MRI.</p></list-item><list-item><p>Assess&#x000a0;the indications for each liver imaging option.</p></list-item><list-item><p>Evaluate&#x000a0;the complications of liver imaging.</p></list-item><list-item><p>Communicate&#x000a0;interprofessional strategies for improving liver imaging.</p></list-item></list>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=67758&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=67758">Access free multiple choice questions on this topic.</ext-link>
</p>
      </sec>
      <sec id="article-67758.s2" sec-type="pubmed-excerpt">
        <title>Introduction</title>
        <p>Liver lesions have a broad spectrum of pathologies, ranging from benign lesions such as hemangiomas to malignant lesions such as primary hepatocellular carcinoma and metastasis. Imaging is a crucial step in diagnosing these conditions, as liver enzymes can be elevated in up to 9% of individuals in the USA.<xref ref-type="bibr" rid="article-67758.r1">[1]</xref><xref ref-type="bibr" rid="article-67758.r2">[2]</xref>&#x000a0;A combination of medical history, serologic, and radiologic investigations can provide a diagnosis in most cases.<xref ref-type="bibr" rid="article-67758.r3">[3]</xref>&#x000a0;Liver lesions can be categorized into focal and diffuse liver lesions.</p>
        <p>
<bold>Focal liver lesions&#x000a0;generally fall into&#x000a0;3 main clinical categories.</bold>
</p>
        <list list-type="order">
          <list-item>
            <p>Benign lesions that do not need treatment if they are asymptomatic, including hepatic hemangiomas, focal nodular hyperplasias, and benign liver cysts</p>
          </list-item>
          <list-item>
            <p>Benign lesions that require treatment, including hepatic adenoma, hepatic abscess, and hepatic adenomas</p>
          </list-item>
          <list-item>
            <p>Malignant lesions, including hepatocellular carcinoma, cholangiocarcinoma, hepatic angiosarcoma, and liver metastases</p>
          </list-item>
        </list>
        <p>
<bold>Diffuse liver lesions can be categorized into vascular, inflammatory, and storage diseases.</bold>
</p>
        <p>
<bold>Benign liver lesions can be classified into&#x000a0;3 categories based on their tissue origin:</bold>
</p>
        <list list-type="order">
          <list-item>
            <p>Cholangiocellar: hepatic cyst, biliary cystadenoma, intraductal papillary neoplasm of the bile ducts, peribiliary cyst, intrahepatic bile adenoma (see <bold>Image.</bold> Hepatic Biloma).</p>
          </list-item>
          <list-item>
            <p>Hepatocellular: focal nodular hyperplasia, hepatic adenoma</p>
          </list-item>
          <list-item>
            <p>Mesenchymal: hemangioma, lipoma</p>
          </list-item>
        </list>
        <p>Liver ultrasonography (US), computed tomography (CT), and magnetic resonance imaging (MRI) are the primary imaging modalities to diagnose liver lesions. Postcontrast imaging&#x000a0;can help distinguish lesions depending on their degree of vascularity and composition. Postcontrast hepatic imaging falls into&#x000a0;3 distinct phases: the arterial phase, the portal venous phase, and the delayed venous phase.<xref ref-type="bibr" rid="article-67758.r4">[4]</xref> Ultrasound can be a method of choice as a screening modality, and contrast-enhanced multidetector CT (MDCT) is a modality of choice in&#x000a0;most hepatic imaging.<xref ref-type="bibr" rid="article-67758.r5">[5]</xref>&#x000a0;MRI plays a role in better-characterizing lesions with equivocal features on US and CT.</p>
      </sec>
      <sec id="article-67758.s3" sec-type="Anatomy">
        <title>Anatomy</title>
        <p>The most widely used anatomic classification of hepatic segments is the Couinaud classification, which describes&#x000a0;8 functionally independent liver segments based on vascularization, bile duct distribution, and lymphatic drainage.<xref ref-type="bibr" rid="article-67758.r6">[6]</xref> Each segment is wedge-shaped, with the apex directed towards the hepatic hilum with some variability.<xref ref-type="bibr" rid="article-67758.r7">[7]</xref> A single branch of the hepatic artery, portal vein, and bile duct enters through the apex into the hepatic segments. The hepatic vein runs between&#x000a0;2 adjacent segments and drains into the inferior vena cava (IVC). The middle hepatic vein runs from the inferior vena cava to the gallbladder fossa&#x000a0;and divides the liver into the right and left lobes.<xref ref-type="bibr" rid="article-67758.r8">[8]</xref>&#x000a0;The right hepatic vein divides the right lobe into the anterior and posterior segments, and the falciform ligament divides the left lobe into medial and lateral segments. The portal vein divides segments&#x000a0;horizontally into superior and inferior segments. Segment I is the unique caudate lobe, which can receive dual blood supply from the right and left portal vein and drains directly into IVC. Segments II, III, and IV are left hepatic lobe sections. Segments V, VI, VII, and VIII constitute the right lobe hepatic sections.<xref ref-type="bibr" rid="article-67758.r9">[9]</xref></p>
        <p>The hepatic blood supply is from the portal vein (about two-thirds), and the rest is from the hepatic artery; thus, maximum enhancement of the liver is attained during the portal venous phase, which is 60 to 120 seconds after arterial phase enhancement.<xref ref-type="bibr" rid="article-67758.r10">[10]</xref>&#x000a0;Tumors supplied from the hepatic artery enhance during the arterial phase, the principle in transarterial chemoembolization and chemoembolization.<xref ref-type="bibr" rid="article-67758.r11">[11]</xref>&#x000a0;Arterial embolization and treatment target tumors rather than normal hepatic cells.<xref ref-type="bibr" rid="article-67758.r12">[12]</xref>&#x000a0;The hepatic veins enter the inferior vena cava. They can be seen as anechoic tubes with thin walls on ultrasound (see <bold>Image.</bold> Color&#x000a0;Doppler&#x000a0;Ultrasound, Hepatic&#x000a0;Veins&#x000a0;With Hepatic Venous&#x000a0;Waveforms). The portal triad, which includes&#x000a0;the portal veins, hepatic arteries, and bile ducts surrounded by fibrofatty tissue, can be seen as echogenic foci throughout the liver.<xref ref-type="bibr" rid="article-67758.r13">[13]</xref></p>
        <p>The portal vein forms from the junction of the superior mesenteric artery and splenic veins behind the neck of the pancreas.<xref ref-type="bibr" rid="article-67758.r14">[14]</xref> Inferior mesenteric, gastric, and cystic veins drain into the portal vein. It divides into the right hepatic vein and porta hepatis. Although the portal vein provides 75% of the liver's blood supply, it provides 50% of its oxygen supply.<xref ref-type="bibr" rid="article-67758.r15">[15]</xref> Portal hypertension or hepatic venous pressure gradient is a portosystemic pressure gradient. Different pathologies can cause portal hypertension, including portal vein thrombosis, cirrhosis, viral hepatitis, Budd-Chiari syndrome, and congestive heart failure.<xref ref-type="bibr" rid="article-67758.r16">[16]</xref> Ultrasound manifestations of portal hypertension are a dilated portal vein (&#x0003e;13 mm), a dilation of the splenic and superior mesenteric veins, the presence of collateral vessels between the portal and systemic pathways, splenomegaly, ascites, and the presence of biphasic or reversed flow (hepatofugal flow) on Doppler US which is diagnostic and pathognomonic for portal hypertension.<xref ref-type="bibr" rid="article-67758.r17">[17]</xref>&#x000a0;Portal hypertension can be appreciated in CT and MRI with similar manifestations&#x000a0;on&#x000a0;ultrasound and the presence of contrast in the paraumbilical vein, which is pathognomonic.</p>
        <p>Hepatomegaly and liver cirrhosis are&#x000a0;2 main pathologies that distort the liver anatomy. Cardiac disease, including congestive heart failure, restrictive cardiomyopathy, and right-sided valvular disease, can cause hepatomegaly and dilation of hepatic veins, called passive hepatic congestion.<xref ref-type="bibr" rid="article-67758.r18">[18]</xref> It is due to hepatic venous drainage impairment and stasis of blood in hepatic parenchyma. Ultrasound&#x000a0;manifestations of passive hepatic congestion are right hepatic lobe enlargement, inferior vena cava dilatation, and hepatic vein enlargement.<xref ref-type="bibr" rid="article-67758.r19">[19]</xref>&#x000a0;Changes in the hepatic vein and IVC velocity pattern can be appreciated in color Doppler ultrasound with loss of normal triphasic flow and flattening of the waveform in hepatic veins.<xref ref-type="bibr" rid="article-67758.r20">[20]</xref> Congestive right heart failure also can cause painless, diffuse wall thickening of the gallbladder.<xref ref-type="bibr" rid="article-67758.r21">[21]</xref><xref ref-type="bibr" rid="article-67758.r22">[22]</xref> The most common etiologies of cirrhosis are alcohol, followed by viral hepatitis, cryptogenic infection, vascular pathologies, and metabolic disorders.<xref ref-type="bibr" rid="article-67758.r23">[23]</xref> The most common ultrasound changes in cirrhosis are a nodular appearance on the surface, heterogeneous echotexture, relative enlargement of the caudate lobe compared to the right lobe, and atrophy of the medial segment of the left lobe. The presence of portal hypertension imaging changes increases the sensitivity and specificity of cirrhosis based on the ultrasound changes, but these usually happen in the advanced and late stages of cirrhosis.<xref ref-type="bibr" rid="article-67758.r3">[3]</xref></p>
      </sec>
      <sec id="article-67758.s4" sec-type="Plain Films">
        <title>Plain Films</title>
        <p>Plain films are rarely helpful in assessing hepatic pathology except for evaluating hepatomegaly when the liver shadow extends beyond the shadow of the right kidney.</p>
      </sec>
      <sec id="article-67758.s5" sec-type="Computed Tomography">
        <title>Computed Tomography</title>
        <p>CT imaging of the liver can be done with different protocols, including unenhanced, single-phase, dual-phase, and triphasic contrast-enhanced protocols.<xref ref-type="bibr" rid="article-67758.r24">[24]</xref> Each of these liver CT protocols&#x000a0;is important in evaluating different liver pathologies.&#x000a0;The single-phase contrast-enhanced CT is generally the modality of choice in the portal&#x000a0;venous phase in CT, which is typically 70 seconds after intravenous (IV) contrast injection, and the liver has the maximum enhancement. It can mainly provide information about diffuse liver pathologies, such as liver cirrhosis and hypovascular metastatic liver disease. The dual-phase contrast-enhanced CT is the primary imaging modality conducted in the portal venous and late arterial phases, which&#x000a0;can be obtained approximately 35 seconds after IV injection and might provide better information about hypervascular lesions.<xref ref-type="bibr" rid="article-67758.r25">[25]</xref>&#x000a0;</p>
        <p>This protocol can help with hypervascular metastatic lesions like renal cell carcinoma, breast cancer, melanoma, and endocrine tumors and preoperative evaluation for partial hepatic resection. It can provide the referring surgeon with information about liver anatomy and vasculature. Triphasic contrast-enhanced CT constitutes non-enhanced arterial and portal venous or arterial, venous, and delayed phases.<xref ref-type="bibr" rid="article-67758.r26">[26]</xref> Arterial phase enhancement begins approximately 20 to 25 seconds after IV contrast injection. Hypervascular pathologies, like most benign and malignant hepatic lesions, can be appreciated in this phase. Triphasic protocols usually are used in patients with possible cirrhosis and hepatocellular carcinoma (HCC).<xref ref-type="bibr" rid="article-67758.r27">[27]</xref>&#x000a0;HCC is a hypervascular lesion that enhances during the arterial phase and has a fast wash-out during the portal venous phase.<xref ref-type="bibr" rid="article-67758.r28">[28]</xref> Cholangiocarcinoma is&#x000a0;1 of the liver pathologies that can be appreciated better on a triphasic CT technique, with non-enhanced, portal venous phase and delayed phase (10 to 15 minutes) hyperenhancement&#x000a0;due to fibrous tissue.<xref ref-type="bibr" rid="article-67758.r29">[29]</xref>&#x000a0;See <bold>Image.</bold>&#x000a0;Cholangiocarcinoma.</p>
        <p>Fatty liver disease is a common condition that can present with different patterns. Because of its important clinical consequences in the long term, radiologists should provide detailed descriptions of fatty changes. The&#x000a0;6 main important patterns of fatty liver infiltrations are diffuse, focal, geographic, subcapsular, multifocal, and perivascular. Fatty liver changes are hyperechoic lesions compared to the spleen and renal cortex.<xref ref-type="bibr" rid="article-67758.r30">[30]</xref> Hepatic steatosis, either diffuse or focal, is best evaluated on a non-contrast CT of the abdomen. In a non-contrast study, the liver measures at least 10 Hounsfield units (HU) less than the spleen in hepatic steatosis.<xref ref-type="bibr" rid="article-67758.r31">[31]</xref>&#x000a0;On a contrast-enhanced CT scan, the liver and spleen have different rates of contrast uptake.&#x000a0;In the portal venous phase, a hepatic attenuation of 25 HU less than the spleen suggests steatosis.<xref ref-type="bibr" rid="article-67758.r32">[32]</xref> Fatty liver disease on MRI can be appreciated by the signal drop in gradient-echo T1-weighted out-of-phase images compared to in-phase.<xref ref-type="bibr" rid="article-67758.r33">[33]</xref></p>
        <p>Diffuse fatty liver is the most common form of liver steatosis. Diffuse steatosis with hepatomegaly and increased caudate-to-right lobe ratio increase the possibility of non-alcoholic steatohepatitis (NASH).<xref ref-type="bibr" rid="article-67758.r34">[34]</xref> Focal hepatic steatosis can have similar imaging features as&#x000a0;specific benign and malignant liver lesions,&#x000a0;and MRI can help differentiate different entities. Areas in the liver that are more susceptible to focal hepatic steatosis are perivascular and subcapsular regions adjacent to the hepatic hilum or falciform ligament, which are the same areas for focal hepatic sparing in the diffuse fatty infiltration as a result of altered intrahepatic blood flow with aberrant venous system and no portal inflow.<xref ref-type="bibr" rid="article-67758.r35">[35]</xref></p>
        <p>Geographic fatty liver disease can&#x000a0;occur secondary to some parenchymal disease like cholangitis, or involvement of the right liver lobe can be related to the feeding of this part of the liver by the superior mesenteric vein, which has lipogenic materials from gastrointestinal tracts. Subcapsular fat deposition can be&#x000a0;visible in insulin-dependent diabetes patients due to fat accumulation in the subcapsular region secondary to higher insulin concentration.<xref ref-type="bibr" rid="article-67758.r36">[36]</xref> Multifocal fat deposition can resemble metastasis, abscesses, lymphoma, sarcoidosis, and hemangiomatosis in the ultrasound and CT, but MRI can differentiate the presence of fat with the signal drop in out-of-phase images.<xref ref-type="bibr" rid="article-67758.r37">[37]</xref> Fat deposition around the portal vein or hepatic vein can have similar ultrasound and CT imaging characteristic features as Budd-Chiari syndrome, periportal edema, and MRI can differentiate fat deposition from other pathologies.</p>
        <p>Non-contrast CT can be useful for evaluating and detecting iron and calcium deposition in the liver. Amyloidosis and Wilson disease mainly have nonspecific liver imaging features. Amyloidosis, abnormal deposition of amyloid fibrils, can have a nonspecific liver imaging manifestation like diffuse hepatomegaly, diffuse or focal areas of hypoattenuation, heterogeneous appearance,&#x000a0;or periportal involvement.<xref ref-type="bibr" rid="article-67758.r38">[38]</xref>&#x000a0;Wilson disease is an autosomal recessive disorder that causes the accumulation of copper in different organs, such as the basal ganglia, cornea, and liver. The CT manifestation of Wilson disease in the liver can be nodular areas&#x000a0;of hyperattenuation due to fatty infiltration and copper accumulation in the liver.<xref ref-type="bibr" rid="article-67758.r39">[39]</xref></p>
        <p>The presence of gas in the portal vein can have various etiologies, and it should be differentiated from pneumobilia. Portal venous gas is peripheral in location, while pneumobilia is central.<xref ref-type="bibr" rid="article-67758.r40">[40]</xref>&#x000a0;It manifests as echogenic foci in the portal vein lumen in the ultrasound and foci of low density in the liver, portal vein, and its branches in CT. Pneumobillia is the presence of gas in the biliary tree, which is more central. Portal venous gas can be caused by umbilical vein catheterization, necrotizing enterocolitis, or postoperative findings in corrective bowel surgery in children. It can be related to ischemic bowel, inflammatory bowel disease, upper and lower endoscopic procedures, and intra-abdominal sepsis in adults.<xref ref-type="bibr" rid="article-67758.r41">[41]</xref> Pneumobillia can be seen in the setting of recent biliary instrumentation, an incompetent sphincter of Oddi, biliary-enteric surgical anastomosis, and spontaneous biliary-enteric fistula.<xref ref-type="bibr" rid="article-67758.r42">[42]</xref></p>
        <p>The hepatic abscess, often a cystic-appearing lesion, usually arises from an infectious process in the gastrointestinal system that carries the infection to the liver via the portal venous system. <italic toggle="yes">Escherichia&#x000a0;coli</italic>&#x000a0;is the most common microorganism.<xref ref-type="bibr" rid="article-67758.r43">[43]</xref>&#x000a0;The imaging characteristic of a hepatic abscess is a double target sign, a central area of low attenuation surrounded by&#x000a0;2 layers of rings.<xref ref-type="bibr" rid="article-67758.r44">[44]</xref> The inner layer can appear as a high attenuation rim, with early and persistent delayed contrast enhancement, and the outer layer enhances only in the delayed phase.&#x000a0;Hepatic abscess imaging features on T2-weighted MRI can demonstrate an irregular wall with late enhancement and central area of T2 hyperintensity.<xref ref-type="bibr" rid="article-67758.r45">[45]</xref>&#x000a0;Due to disseminated candidiasis, fungemia is another infection process that can occur in immunocompromised patients. Liver and spleen involvement is visible in CT as multiple small hypoattenuating lesions, which may have ring-enhancing and look like microabscesses. Although MRI has better sensitivity and specificity, CT has been used more frequently because it is less expensive and more accessible.<xref ref-type="bibr" rid="article-67758.r46">[46]</xref></p>
      </sec>
      <sec id="article-67758.s6" sec-type="Magnetic Resonance">
        <title>Magnetic Resonance</title>
        <p>MRI has advantages and disadvantages compared to ultrasound and CT. Lack of ionizing radiation, higher cross-sectional resolution, presence of extracellular and hepatocyte-specific contrast agents, and the ability to give better and more accurate information about the diffuse liver lesion and characterization of focal liver lesions make MRI the best imaging modality in liver imaging. However, it costs more, takes longer to acquire images, and requires&#x000a0;patient cooperation, such as breath-holding, to have better and fewer motion artifacts (see&#x000a0;<bold>Image.</bold>&#x000a0;Aliasing Artifact).<xref ref-type="bibr" rid="article-67758.r47">[47]</xref></p>
        <p>The liver MRI protocol consists of multiple sequences before and post-contrast. Post-contrast phases include the arterial phase, portal venous phase, equilibrium phase, hepatobiliary delayed phase, and later delayed phase.<xref ref-type="bibr" rid="article-67758.r48">[48]</xref>&#x000a0;Hepatobiliary-specific contrast agents that are used in liver MRI are mangafodipir trisodium (Mn-DPDP), gadobenate dimeglumine (Gd-BOPTA), and gadoxetic acid (Gd-EOB-DTPA). These contrast agents have specific characteristics such as specific receptors and transporters for uptake, different excretion percentages via the biliary and renal systems, method of administration, and side effects.&#x000a0;These hepatocyte-specific contrasts can better help identify and characterize small liver lesions, especially well-differentiated HCC. It can be used to distinguish FNH from hepatic adenoma. Hepatic adenoma is visible in the hepatobiliary phase as a hypointense lesion versus FNH that is iso or hyperintense when evaluating hepatic disease&#x000a0;during HCC surveillance and post-liver transplant evaluation. It can also differentiate tumors with a hepatocellular origin from nonhepatocellular ones.<xref ref-type="bibr" rid="article-67758.r49">[49]</xref>&#x000a0;Contrast agents secreted into bile can differentiate hepatocellular adenoma (HCA) by early heterogeneous enhancement in T1-weighted fat-suppressed arterial phase MRI and subsequent contrast washout&#x000a0;in the portal venous phase. Because HCA has no bile ducts, uptake of biliary-specific contrast is minimal in the delayed phase.<xref ref-type="bibr" rid="article-67758.r50">[50]</xref></p>
        <p>The most sensitive imaging technique to assess the presence and degree of hepatic steatosis is in and out gradient recalled echo (GRE) MRI. However, a liver biopsy is the gold standard method to evaluate the presence of inflammatory and early fibrotic changes.<xref ref-type="bibr" rid="article-67758.r50">[50]</xref>&#x000a0;Magnetic resonance elastography is a newer technique introduced originally as ultrasound elastography, which can measure liver stiffness and degree of fibrosis.<xref ref-type="bibr" rid="article-67758.r51">[51]</xref> Magnetic resonance elastography does not have the possible sampling bias in liver biopsy. It has better sensitivity and specificity compared to&#x000a0;ultrasound elastography, which has limitations in obese patients and patients with ascites. Iron overload and accumulation in hepatic and hepatic Kupffer cells can occur in hemochromatosis and hemosiderosis. The liver is the primary organ of deposition and can present as hepatomegaly as the first sign of disease.<xref ref-type="bibr" rid="article-67758.r52">[52]</xref> It can be seen as hypointense compared to paraspinal muscle signal in T1 and T2 Weighted and GRE T2 weighting MRI.<xref ref-type="bibr" rid="article-67758.r53">[53]</xref></p>
        <p>Hepatic hemangioma is the most common benign liver lesion that can be categorized into typical and atypical hemangiomas. A typical hepatic hemangioma can be appreciated on non-contrast CT as a hypo-attenuating lesion most of the time. In arterial phase contrast-enhanced CT, these neoplasms present as a lesion with nodular enhancement in the periphery.&#x000a0;Portal venous and delayed phases show&#x000a0;continuous enhancement of the periphery with contrast filling the central part.<xref ref-type="bibr" rid="article-67758.r54">[54]</xref>&#x000a0;Hemangioma is hypointense on T1 imaging and hyperintense on T2 imaging. Gadolinium-enhanced contrast T1 imaging often shows nodular enhancement of the periphery with a progressive enhancement of the central part and retaining the contrast in delayed imaging. Hepatobiliary contrast T1 imaging is non-specific and may not be helpful. Two main categories for atypical hemangiomas are giant hepatic hemangiomas and flash-filling hepatic hemangiomas. Giant hemangiomas are remarkably large but non-neoplastic vascular lesions with radiologic manifestations similar to hepatic hemangiomas.<xref ref-type="bibr" rid="article-67758.r55">[55]</xref>&#x000a0;Flash-filling hepatic hemangiomas/venous malformations are smaller (mostly less than 2 cm) and have a hyperechoic appearance in the ultrasound.<xref ref-type="bibr" rid="article-67758.r56">[56]</xref>&#x000a0;They are hypo- or iso-dense in noncontract imaging and demonstrate a fast and homogenous enhancement in the arterial phase while retaining the contrast in the late phase. Flash-filling hemangiomas have similar imaging manifestations in CEUS and gadolinium-enhanced contrast MRI with quick, homogenous enhancement and no washout in the late phase.</p>
        <p>Focal nodular hyperplasia (FNH) is the second most common benign liver mass with a hepatocellular origin. It has a central scar with fat and fibrous tissue contents and an increased density of hepatocytes in about 80% of FNH.<xref ref-type="bibr" rid="article-67758.r57">[57]</xref>&#x000a0;MRI has better sensitivity and specificity in diagnosing FNH than CT and ultrasound. FNH&#x000a0;consists of hepatocytes, bile ducts, and Kupffer cells in an abnormal alignment. The ultrasound appearance of FNH includes subtle changes in the liver contour or parenchymal echogenicity.<xref ref-type="bibr" rid="article-67758.r57">[57]</xref>&#x000a0;FNH is iso- or hypointense in nonenhanced T1 imaging and has a homogenous enhancement&#x000a0;on the arterial phase. FNH can be appreciated in multiphasic MRI with hyperintense and delayed enhancement in T2 weighted images due to retaining contrast in hepatocytes because of a central scar.<xref ref-type="bibr" rid="article-67758.r57">[57]</xref></p>
        <p>Hepatic adenomas are rare and benign liver tumors&#x000a0;with a hepatocellular origin, most commonly related to long-term oral contraceptive use.<xref ref-type="bibr" rid="article-67758.r58">[58]</xref> Other factors precipitating hepatic adenomas are anabolic steroids, glycogen storage diseases, obesity, and metabolic syndrome.<xref ref-type="bibr" rid="article-67758.r59">[59]</xref>&#x000a0;Although hepatic adenomas are benign liver tumors, they have a potential risk of bleeding and malignant degeneration.<xref ref-type="bibr" rid="article-67758.r60">[60]</xref> Surgical resection is the recommended treatment for hepatic adenomas.&#x000a0;For patients in which resection is not feasible or not preferable, modifying risk factors,&#x000a0;serial&#x000a0;imaging, and monitoring alpha-fetoprotein levels are possible management options. Hepatic arterial embolization can be considered in select cases.<xref ref-type="bibr" rid="article-67758.r61">[61]</xref></p>
        <p>A hepatic cyst is a common hepatic lesion with a cholangiocellular origin. Benign hepatic cyst(s) can be found in around 5% of the general population.<xref ref-type="bibr" rid="article-67758.r62">[62]</xref>&#x000a0;Its size can vary from microscopic to sometimes greater than 20 cm in diameter.<xref ref-type="bibr" rid="article-67758.r63">[63]</xref>&#x000a0;Ultrasound&#x000a0;can characterize hepatic cysts as anechoic lesions with thin walls and the presence of posterior acoustic enhancement, which confirms the fluid content of the cyst and very thin septa in some&#x000a0;cases. CT imaging can be appreciated as an area of low internal attenuation with a thin wall and the possible presence of thin septa. Cysts can be appreciated in the MRI as an area of homogenous low signal in T1-weighted imaging, homogenous high internal signal in T2-weighted imaging, and absence of enhancement with contrast.<xref ref-type="bibr" rid="article-67758.r64">[64]</xref>&#x000a0;See <bold>Image.</bold> Hepatic Cysts.</p>
        <p>Hepatocellular carcinoma (HCC) is the most common primary liver tumor. Cirrhosis and chronic hepatitis are the major risk factors for the development of HCC. Alpha-fetoprotein becomes elevated in two-thirds of HCC.&#x000a0;Elevated alpha-fetoprotein in the presence of cirrhosis is suggestive of HCC and can be seen in 70% of patients with HCC.<xref ref-type="bibr" rid="article-67758.r65">[65]</xref><xref ref-type="bibr" rid="article-67758.r66">[66]</xref> HCC can appear on&#x000a0;ultrasound&#x000a0;from focal hypoechoic, hyperechoic, and heterogeneous lesions. Most HCCs are hypervascular on color Doppler. In contrast-enhanced ultrasound, HCC can be appreciated with enhancement in the arterial phase and washout on the portal venous phase.<xref ref-type="bibr" rid="article-67758.r67">[67]</xref>&#x000a0;MRI and CT have 82% and 56% sensitivity in detecting HCC, respectively.<xref ref-type="bibr" rid="article-67758.r68">[68]</xref><xref ref-type="bibr" rid="article-67758.r69">[69]</xref> In CT, the enhancement pattern is similar to contrast-enhanced ultrasound. Because of the possible arterioportal shunt in HCC, focal fatty changes might be seen as focal fat deposition in the normal liver or focal fat sparing around the HCC in diffuse hepatic steatosis. HCC results from a regenerative nodule's progression to dysplastic nodules and high-grade dysplastic nodules to low-grade HCC. The portal vein feeds regenerative and dysplastic nodules, which are indistinguishable from each other on imaging, although dysplastic nodules are premalignant, and regenerative nodules are not. Most regenerative and dysplastic nodules are hypo-intense in T2- T2-weighted images and have variable intensity in T1- T1-weighted images. Regenerative nodules and low-grade dysplastic nodules are isointense in contrast-enhanced MRI.<xref ref-type="bibr" rid="article-67758.r70">[70]</xref>&#x000a0;<xref ref-type="bibr" rid="article-67758.r71">[71]</xref>&#x000a0;</p>
        <p>Hepatocellular carcinoma (HCC) receives blood from the hepatic artery compared to healthy hepatic tissue that gets supply from the portal vein. Because of this characteristic, HCC can be appreciated in multiphasic, contrast-enhanced MRI by increasing contrast enhancement in the arterial phase and contrast washout in the portal phase with peripheral rim enhancement. HCC appears slightly hyperintense T2-weighted unenhanced MRI. The hepatic artery and portal vein feed&#x000a0;cholangiocarcinoma, so there is an increasing contrast enhancement in both arterial and venous phases.<xref ref-type="bibr" rid="article-67758.r50">[50]</xref><xref ref-type="bibr" rid="article-67758.r70">[70]</xref></p>
        <p>Fibrolamellar carcinoma is a subtype of HCC and&#x000a0;has a better prognosis than the typical HCC. These generally occur in younger patients and do not demonstrate elevated alpha-fetoprotein levels. Fibrolamellar HCC&#x000a0;on imaging is usually large at diagnosis and does not have a capsule. Fibrolamellar carcinoma appears&#x000a0;on T1- and T2-weighted MRI as a large, heterogeneous mass with central hypointensity due to central fibrotic scar.<xref ref-type="bibr" rid="article-67758.r72">[72]</xref></p>
        <p>Metastatic liver lesions are usually hypointense on T1-weighted imaging and hyperintense on T2-weighted images. Most metastatic liver tumors are hypovascular, and the portal venous phase is the phase for visualization. Some metastatic tumors, including renal cell carcinoma, melanoma, and sarcoma, are hypervascular. These liver metastases can be appreciated best in the arterial phase.<xref ref-type="bibr" rid="article-67758.r73">[73]</xref></p>
      </sec>
      <sec id="article-67758.s7" sec-type="Ultrasonography">
        <title>Ultrasonography</title>
        <p>Ultrasonography is often the first imaging modality&#x000a0;in evaluating and screening for focal and diffuse&#x000a0;liver pathologies due to&#x000a0;its availability, low cost, and noninvasive.<xref ref-type="bibr" rid="article-67758.r74">[74]</xref>&#x000a0;Liver pathology on ultrasound can present with different patterns such as generalized hypoechogenicity, as seen in acute hepatitis and diffuse malignant lesions, generalized hyperechogenicity, as seen in diffuse hepatic steatosis, and anechoic/hyperechoic lesions as seen in various benign and malignant lesions. Benign hyperechoic lesions include hemangioma, hepatic adenoma, focal nodular hyperplasia, and focal fatty changes. Malignant hyperechoic lesions include hepatic metastases from colorectal, renal cell carcinoma, melanoma, cholangiocarcinoma, and HCC.<xref ref-type="bibr" rid="article-67758.r75">[75]</xref>&#x000a0;Ultrasonography has limitations, including&#x000a0;interobserver variability and decreased accuracy in patients with large body habitus.<xref ref-type="bibr" rid="article-67758.r49">[49]</xref></p>
        <p>Ultrasonography, in combination with techniques and tools, has a significant role in diagnosing and treating different liver pathologies, for example:</p>
        <list list-type="order">
          <list-item>
            <p>Ultrasound with color Doppler can provide information about the liver vasculature; for example, it can provide information about the portal vein flow and direction. Normally the portal vein blood flows away from the liver (hepatopetal flow). Retrograde flow from the periphery to the central area can suggest liver cirrhosis with portal hypertension. Doppler ultrasound can assess the patency of the portal vein before transplant and evaluate hepatic artery thrombosis after the transplant.<xref ref-type="bibr" rid="article-67758.r76">[76]</xref></p>
          </list-item>
          <list-item>
            <p>The contrast-enhanced US (CEUS) usage has grown during the past few years. CEUS needs considerable training, and it is very dependent on operator skills. It can have 95.8% sensitivity and 83.1% specificity in diagnosing focal liver lesions in healthy livers.<xref ref-type="bibr" rid="article-67758.r77">[77]</xref> CEUS can provide information about vessel architecture, microcirculation within the focal liver lesions, and the malignant versus benign nature of the tumors.<xref ref-type="bibr" rid="article-67758.r78">[78]</xref></p>
          </list-item>
          <list-item>
            <p>A percutaneous liver biopsy is possible under ultrasound or CT guidance. Ultrasound is the modality of choice for both non-focal liver biopsy and focal, targeted biopsy in select cases with a good target window. A CT-guided biopsy is mainly reserved for lesion(s) not visible on ultrasound.<xref ref-type="bibr" rid="article-67758.r79">[79]</xref> Indications for focal liver biopsies are unknown focal liver lesions and the presence of metastasis in the liver without a specific source. Indications for non-focal liver biopsy are the staging of parenchymal diseases like cirrhosis, primary biliary cirrhosis, and non-alcoholic fatty liver disease, determining the presence of rejection after liver transplant, assessment of hepatic storage disease, and the presence of abnormal liver function tests without other findings of any specific etiology. In&#x000a0;cases of coagulopathy and severe ascites, transjugular liver biopsy is the alternate choice of percutaneous biopsy.<xref ref-type="bibr" rid="article-67758.r80">[80]</xref></p>
          </list-item>
          <list-item>
            <p>Ultrasound-guided percutaneous drainage can be useful for any abnormal fluid collection, such as abscesses of different etiologies. There are some advantages and disadvantages in comparison to CT-guided percutaneous drainage. The advantages are no exposure to ionizing radiation, flexible study with more control on the needle insertion, and&#x000a0;less&#x000a0;personnel needed for the procedure. It has limitations in deep lesions not visible on ultrasound, and bowel gas may limit the field of view.<xref ref-type="bibr" rid="article-67758.r81">[81]</xref></p>
          </list-item>
          <list-item>
            <p>&#x000a0;Endoscopic ultrasound (EUS) has become a diagnostic and therapeutic method in different gastrointestinal and pancreaticobiliary diseases, including diagnosis and therapeutic use in portal hypertensive diseases like esophageal varices, EUS-guided focal liver lesions biopsy, EUS-guided portal venous access, EUS-guided portal vein embolization to induce lobar atrophy in the liver, and EUS-guided portal vein injection of chemotherapy. EUS is more sensitive than cross-sectional imaging in identifying small lesions less than 10 mm.<xref ref-type="bibr" rid="article-67758.r82">[82]</xref></p>
          </list-item>
          <list-item>
            <p>Ultrasound-based elastography is a noninvasive method to assess hepatic fibrosis instead of liver biopsy and predict complications in patients with liver cirrhosis. The most common techniques are the shear wave elastography (SWE) technique and acoustic radiation force impulse techniques. Shear wave elastography can be performed using several methods, including transient elastography, point-SWE, and 2-dimensional (2D)-SWE.<xref ref-type="bibr" rid="article-67758.r83">[83]</xref></p>
          </list-item>
        </list>
        <p>A cirrhotic liver can appear hyperechoic&#x000a0;on ultrasound. The sensitivity of diagnosing cirrhosis by&#x000a0;ultrasound can vary and be as high as 91%.<xref ref-type="bibr" rid="article-67758.r84">[84]</xref> The presence of signs and symptoms of portal hypertension, such as increased spleen or portal vein diameter, can increase the sensitivity of ultrasound in later stages of cirrhosis.<xref ref-type="bibr" rid="article-67758.r3">[3]</xref>&#x000a0;A hypervascular nodule in CEUS has a higher specificity for small HCC, less than 2 cm, than CT and MRI studies. Liver metastasis appearance mainly depends on the primary source of the tumor. It can appear as hypoechoic or hyperechoic lesions.&#x000a0;The presence&#x000a0;of a hyperechoic halo sign is suggestive of a malignant lesion.<xref ref-type="bibr" rid="article-67758.r85">[85]</xref> In CEUS, metastasis has variable echogenicity in the arterial phase, but the washout appearance&#x000a0;on the portal phase can help detect malignant lesions.<xref ref-type="bibr" rid="article-67758.r86">[86]</xref></p>
        <p>One of the important applications of the Doppler ultrasound is in post-transplant patients. Hepatic arterial thrombosis is the most common vascular complication after a liver transplant. The resistive index (RI) is a Doppler parameter to evaluate it, measured by subtraction of peak systolic velocity from end-diastolic velocity, divided by peak systolic velocity.<xref ref-type="bibr" rid="article-67758.r87">[87]</xref> The RI normal range is between 0.55 to 0.8. Low RI is more specific in patients with a liver transplant, which can be related to partial arterial obstruction in the proximal part of the artery, peripheral vascular shunts, and portal hypertension. In comparison, high RI can be related to microvascular compression, disease, or physiologic.<xref ref-type="bibr" rid="article-67758.r88">[88]</xref></p>
        <p>Hemangioma is the most common benign liver lesion. It is usually an incidental finding in asymptomatic patients as the&#x000a0;most common hyperechoic liver lesion.<xref ref-type="bibr" rid="article-67758.r54">[54]</xref> It&#x000a0;can&#x000a0;appear on ultrasound as a hyperechoic lesion with a distinct border and peripheral feeding vessel on color Doppler.<xref ref-type="bibr" rid="article-67758.r56">[56]</xref><xref ref-type="bibr" rid="article-67758.r89">[89]</xref>&#x000a0;A hemangioma appears in the arterial phase of CEUS with peripheral nodular enhancement, portal venous phase, and late phase with continuous contrast filling and changing to a hyperechoic lesion. In asymptomatic patients without any history of malignancy, diagnosis of hemangioma can be made solely based on imaging manifestation of&#x000a0;a single, well-defined, homogenously hyperechoic lesion in the ultrasound; no further workup is necessary.<xref ref-type="bibr" rid="article-67758.r90">[90]</xref></p>
        <p>The imaging manifestation of viral hepatitis in ultrasound can range from normal to nonspecific findings of hepatomegaly, gallbladder wall thickening, fluid accumulation around the portal vein, or generalized hypoechogenicity.<xref ref-type="bibr" rid="article-67758.r91">[91]</xref>&#x000a0;The diagnosis is mainly made based on clinical features and serology testing.&#x000a0;</p>
      </sec>
      <sec id="article-67758.s8" sec-type="Nuclear Medicine">
        <title>Nuclear Medicine</title>
        <p>Positron emission tomography (PET) and single-photon emission computed tomography (SPECT) are the nuclear imaging techniques used more frequently to diagnose liver malignancy and evaluate response to treatment metastasis, recurrence, and prognosis. F-fluorodeoxyglucose (FDG)-PET and C-acetate PET are more common nuclear imaging modalities in diagnosing liver malignancy.<xref ref-type="bibr" rid="article-67758.r92">[92]</xref> Although it has high sensitivity, the false positive rate is high due to detecting any focal hypermetabolism area. The sensitivity is low in the detection of lesions smaller than 1 cm. Transarterial radioembolization and selective internal radiotherapy are theragnosis methods in the nuclear medicine field, and PET or SPECT is used simultaneously for diagnosis and treatment.<xref ref-type="bibr" rid="article-67758.r93">[93]</xref></p>
      </sec>
      <sec id="article-67758.s9" sec-type="Angiography">
        <title>Angiography</title>
        <p>Multidetector computed tomography angiography (MDCT) is an imaging method to assess liver neoplasm for staging and surgical planning by&#x000a0;providing information about hepatic vascular anatomy and parenchymal pathology. Biphasic hepatic CT with arterial and portal venous phases can appreciate hypervascular tumors with increased sensitivity than the portal phase alone. MDCT angiography&#x000a0;has been the imaging modality of choice for living donor liver transplantation and evaluating any arterial complications after the transplant.<xref ref-type="bibr" rid="article-67758.r94">[94]</xref></p>
        <p>Transarterial chemoembolization therapy (TACE) is a method in which chemotherapy is administered directly into the hepatic artery, feeding the tumor and resulting in necrosis. Its primary use is treating HCC and specific liver metastasis, such as colorectal metastases and cholangiocarcinoma. It can also be useful for unresectable HCC.<xref ref-type="bibr" rid="article-67758.r95">[95]</xref></p>
      </sec>
      <sec id="article-67758.s10" sec-type="Patient Positioning">
        <title>Patient Positioning</title>
        <p>Ultrasound is the main liver imaging technique, and patient positioning and operator expertise are important factors in optimizing the study.<xref ref-type="bibr" rid="article-67758.r96">[96]</xref></p>
      </sec>
      <sec id="article-67758.s11" sec-type="Clinical Significance">
        <title>Clinical Significance</title>
        <p>The first imaging modality to evaluate liver pathology depends on the patient's clinical situation, the availability of different modalities, the technician's familiarity with the test, and the physician's familiarity with the test. Ultrasound and CT remain the first imaging modality to assess the diffuse and focal liver lesion for screening and characterization. Based on the findings of ultrasound and CT, further workup and imaging can occur.</p>
        <p>Hepatic steatosis or fatty liver is the most common abnormal imaging finding in liver imaging, which can be related to alcoholic liver disease and nonalcoholic liver disease, including obesity, insulin resistance, diabetes, hyperlipidemia, and hypertension. Nonalcoholic fatty liver disease can progress from simple fatty liver disease to nonalcoholic steatohepatitis (NASH) and cirrhosis. Regardless of etiology, ultrasound findings of fatty liver disease include increased echogenicity of the liver compared to the renal cortex, loss of normal echogenicity of the portal triad in the periphery of the liver,&#x000a0;and poor visualization of the diaphragm. Transient elastography is the most validated technique with more sensitivity and specificity (87% and 91%, respectively) in diagnosing cirrhosis than diagnosing significant fibrosis (70% and 84%, respectively).<xref ref-type="bibr" rid="article-67758.r97">[97]</xref></p>
        <p>Risk stratification is essential in patients with liver cirrhosis to estimate complications risks such as portal hypertension consequences and liver cancer. Liver serology and elastography are noninvasive methods to determine patients with advanced liver cirrhosis. A liver biopsy can provide information about the stages of fibrosis.&#x000a0;Elastography is a method that can show the increased stiffness of the parenchyma. Among the different approaches to elastography, vibration-controlled transient elastography is the most common type used worldwide.<xref ref-type="bibr" rid="article-67758.r3">[3]</xref></p>
        <p>Liver Imaging Reporting and Data System (LI-RADS) is a comprehensive and standardized system&#x000a0;for reporting and classifying liver lesions at an increased risk of developing into HCC.<xref ref-type="bibr" rid="article-67758.r98">[98]</xref> LIRAD categorizes lesions into definitely benign, probably benign, probably or malignant, but not HCC specific, intermediate probability of malignancy, probably HCC, and HCC. It guides radiologists, clinicians, and surgeons for surveillance guidelines and recommendations if a biopsy is necessary.</p>
      </sec>
      <sec id="article-67758.s12">
        <title>Review Questions</title>
        <list list-type="bullet">
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=67758&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=67758">Access free multiple choice questions on this topic.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/articlelibrary/commentarticle/67758/?utm_source=pubmed&#x00026;utm_campaign=comments&#x00026;utm_content=67758">Comment on this article.</ext-link>
</p>
          </list-item>
        </list>
      </sec>
    </body>
    <back>
      <floats-group id="article-67758.s13">
        <fig id="article-67758.image.f1" position="float" orientation="portrait">
          <caption>
            <p>Cholangiocarcinoma. Axial T2 Haste, 20s, and 3-minute post-contrast T1 Vibe images are submitted. There is marked biliary dilatation, greatest in the left biliary tree. A delayed enhancing hilar mass is identified, which is biopsy proven to be cholangiocarcinoma. This mass has increased T2 signal in comparison to the background liver parenchyma. Mild capsular retraction in the right hepatic lobe is noted. Contributed by M Smith, MD</p>
          </caption>
          <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="NJ__cholangio__hilar" position="float" orientation="portrait"/>
        </fig>
      </floats-group>
      <floats-group id="article-67758.s14">
        <fig id="article-67758.image.f2" position="float" orientation="portrait">
          <caption>
            <p>Aliasing Artifact. The image is a hepatic venous Doppler ultrasound showing an aliasing artifact. Contributed by B Covello, MD</p>
          </caption>
          <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="q1a" position="float" orientation="portrait"/>
        </fig>
      </floats-group>
      <floats-group id="article-67758.s15">
        <fig id="article-67758.image.f3" position="float" orientation="portrait">
          <caption>
            <p>Color Doppler Ultrasound, Hepatic Veins With Hepatic Venous Waveforms Contributed by B Covello, MD</p>
          </caption>
          <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="q3" position="float" orientation="portrait"/>
        </fig>
      </floats-group>
      <floats-group id="article-67758.s16">
        <fig id="article-67758.image.f4" position="float" orientation="portrait">
          <caption>
            <p>Hepatic Cysts Contributed by Khadija Ghumman</p>
          </caption>
          <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="Stat__Pearls__Hepatic__Cysts" position="float" orientation="portrait"/>
        </fig>
      </floats-group>
      <floats-group id="article-67758.s17">
        <fig id="article-67758.image.f5" position="float" orientation="portrait">
          <caption>
            <p>Hepatic Biloma. This CT image shows hepatic biloma. Contributed by R Kabir, MD</p>
          </caption>
          <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="Kabir_Hepatic__Bioloma__CT" position="float" orientation="portrait"/>
        </fig>
      </floats-group>
      <ref-list id="article-67758.s18">
        <title>References</title>
        <ref id="article-67758.r1">
          <label>1</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Hultcrantz</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Glaumann</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Lindberg</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Nilsson</surname>
                <given-names>LH</given-names>
              </name>
            </person-group>
            <article-title>Liver investigation in 149 asymptomatic patients with moderately elevated activities of serum aminotransferases.</article-title>
            <source>Scand J Gastroenterol</source>
            <year>1986</year>
            <month>Jan</month>
            <volume>21</volume>
            <issue>1</issue>
            <fpage>109</fpage>
            <page-range>109-13</page-range>
            <pub-id pub-id-type="pmid">3952445</pub-id>
          </element-citation>
        </ref>
        <ref id="article-67758.r2">
          <label>2</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Ioannou</surname>
                <given-names>GN</given-names>
              </name>
              <name>
                <surname>Boyko</surname>
                <given-names>EJ</given-names>
              </name>
              <name>
                <surname>Lee</surname>
                <given-names>SP</given-names>
              </name>
            </person-group>
            <article-title>The prevalence and predictors of elevated serum aminotransferase activity in the United States in 1999-2002.</article-title>
            <source>Am J Gastroenterol</source>
            <year>2006</year>
            <month>Jan</month>
            <volume>101</volume>
            <issue>1</issue>
            <fpage>76</fpage>
            <page-range>76-82</page-range>
            <pub-id pub-id-type="pmid">16405537</pub-id>
          </element-citation>
        </ref>
        <ref id="article-67758.r3">
          <label>3</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Tapper</surname>
                <given-names>EB</given-names>
              </name>
              <name>
                <surname>Lok</surname>
                <given-names>AS</given-names>
              </name>
            </person-group>
            <article-title>Use of Liver Imaging and Biopsy in Clinical Practice.</article-title>
            <source>N Engl J Med</source>
            <year>2017</year>
            <month>Aug</month>
            <day>24</day>
            <volume>377</volume>
            <issue>8</issue>
            <fpage>756</fpage>
            <page-range>756-768</page-range>
            <pub-id pub-id-type="pmid">28834467</pub-id>
          </element-citation>
        </ref>
        <ref id="article-67758.r4">
          <label>4</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Maniam</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Szklaruk</surname>
                <given-names>J</given-names>
              </name>
            </person-group>
            <article-title>Magnetic resonance imaging: Review of imaging techniques and overview of liver imaging.</article-title>
            <source>World J Radiol</source>
            <year>2010</year>
            <month>Aug</month>
            <day>28</day>
            <volume>2</volume>
            <issue>8</issue>
            <fpage>309</fpage>
            <page-range>309-22</page-range>
            <pub-id pub-id-type="pmid">21160685</pub-id>
          </element-citation>
        </ref>
        <ref id="article-67758.r5">
          <label>5</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Zhang</surname>
                <given-names>YN</given-names>
              </name>
              <name>
                <surname>Fowler</surname>
                <given-names>KJ</given-names>
              </name>
              <name>
                <surname>Hamilton</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Cui</surname>
                <given-names>JY</given-names>
              </name>
              <name>
                <surname>Sy</surname>
                <given-names>EZ</given-names>
              </name>
              <name>
                <surname>Balanay</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Hooker</surname>
                <given-names>JC</given-names>
              </name>
              <name>
                <surname>Szeverenyi</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Sirlin</surname>
                <given-names>CB</given-names>
              </name>
            </person-group>
            <article-title>Liver fat imaging-a clinical overview of ultrasound, CT, and MR imaging.</article-title>
            <source>Br J Radiol</source>
            <year>2018</year>
            <month>Sep</month>
            <volume>91</volume>
            <issue>1089</issue>
            <fpage>20170959</fpage>
            <pub-id pub-id-type="pmid">29722568</pub-id>
          </element-citation>
        </ref>
        <ref id="article-67758.r6">
          <label>6</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Fasel</surname>
                <given-names>JH</given-names>
              </name>
              <name>
                <surname>Majno</surname>
                <given-names>PE</given-names>
              </name>
              <name>
                <surname>Peitgen</surname>
                <given-names>HO</given-names>
              </name>
            </person-group>
            <article-title>Liver segments: an anatomical rationale for explaining inconsistencies with Couinaud's eight-segment concept.</article-title>
            <source>Surg Radiol Anat</source>
            <year>2010</year>
            <month>Oct</month>
            <volume>32</volume>
            <issue>8</issue>
            <fpage>761</fpage>
            <page-range>761-5</page-range>
            <pub-id pub-id-type="pmid">20111966</pub-id>
          </element-citation>
        </ref>
        <ref id="article-67758.r7">
          <label>7</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Fischer</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Cardenas</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Thorn</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Benner</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Grenacher</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Vetter</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Lehnert</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Klar</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Meinzer</surname>
                <given-names>HP</given-names>
              </name>
              <name>
                <surname>Lamad&#x000e9;</surname>
                <given-names>W</given-names>
              </name>
            </person-group>
            <article-title>Limits of Couinaud's liver segment classification: a quantitative computer-based three-dimensional analysis.</article-title>
            <source>J Comput Assist Tomogr</source>
            <year>2002</year>
            <season>Nov-Dec</season>
            <volume>26</volume>
            <issue>6</issue>
            <fpage>962</fpage>
            <page-range>962-7</page-range>
            <pub-id pub-id-type="pmid">12488744</pub-id>
          </element-citation>
        </ref>
        <ref id="article-67758.r8">
          <label>8</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Lafortune</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Madore</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Patriquin</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Breton</surname>
                <given-names>G</given-names>
              </name>
            </person-group>
            <article-title>Segmental anatomy of the liver: a sonographic approach to the Couinaud nomenclature.</article-title>
            <source>Radiology</source>
            <year>1991</year>
            <month>Nov</month>
            <volume>181</volume>
            <issue>2</issue>
            <fpage>443</fpage>
            <page-range>443-8</page-range>
            <pub-id pub-id-type="pmid">1924786</pub-id>
          </element-citation>
        </ref>
        <ref id="article-67758.r9">
          <label>9</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Pauli</surname>
                <given-names>EM</given-names>
              </name>
              <name>
                <surname>Staveley-O'Carroll</surname>
                <given-names>KF</given-names>
              </name>
              <name>
                <surname>Brock</surname>
                <given-names>MV</given-names>
              </name>
              <name>
                <surname>Efron</surname>
                <given-names>DT</given-names>
              </name>
              <name>
                <surname>Efron</surname>
                <given-names>G</given-names>
              </name>
            </person-group>
            <article-title>A handy tool to teach segmental liver anatomy to surgical trainees.</article-title>
            <source>Arch Surg</source>
            <year>2012</year>
            <month>Aug</month>
            <volume>147</volume>
            <issue>8</issue>
            <fpage>692</fpage>
            <page-range>692-3</page-range>
            <pub-id pub-id-type="pmid">22911067</pub-id>
          </element-citation>
        </ref>
        <ref id="article-67758.r10">
          <label>10</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Itoh</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Ikeda</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Achiwa</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Satake</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Iwano</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Ishigaki</surname>
                <given-names>T</given-names>
              </name>
            </person-group>
            <article-title>Late-arterial and portal-venous phase imaging of the liver with a multislice CT scanner in patients without circulatory disturbances: automatic bolus tracking or empirical scan delay?</article-title>
            <source>Eur Radiol</source>
            <year>2004</year>
            <month>Sep</month>
            <volume>14</volume>
            <issue>9</issue>
            <fpage>1665</fpage>
            <page-range>1665-73</page-range>
            <pub-id pub-id-type="pmid">15067427</pub-id>
          </element-citation>
        </ref>
        <ref id="article-67758.r11">
          <label>11</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Brancatelli</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Federle</surname>
                <given-names>MP</given-names>
              </name>
              <name>
                <surname>Baron</surname>
                <given-names>RL</given-names>
              </name>
              <name>
                <surname>Lagalla</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Midiri</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Vilgrain</surname>
                <given-names>V</given-names>
              </name>
            </person-group>
            <article-title>Arterially enhancing liver lesions: significance of sustained enhancement on hepatic venous and delayed phase with magnetic resonance imaging.</article-title>
            <source>J Comput Assist Tomogr</source>
            <year>2007</year>
            <season>Jan-Feb</season>
            <volume>31</volume>
            <issue>1</issue>
            <fpage>116</fpage>
            <page-range>116-24</page-range>
            <pub-id pub-id-type="pmid">17259843</pub-id>
          </element-citation>
        </ref>
        <ref id="article-67758.r12">
          <label>12</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Rammohan</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Sathyanesan</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Ramaswami</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Lakshmanan</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Senthil-Kumar</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Srinivasan</surname>
                <given-names>UP</given-names>
              </name>
              <name>
                <surname>Ramasamy</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Ravichandran</surname>
                <given-names>P</given-names>
              </name>
            </person-group>
            <article-title>Embolization of liver tumors: Past, present and future.</article-title>
            <source>World J Radiol</source>
            <year>2012</year>
            <month>Sep</month>
            <day>28</day>
            <volume>4</volume>
            <issue>9</issue>
            <fpage>405</fpage>
            <page-range>405-12</page-range>
            <pub-id pub-id-type="pmid">23024842</pub-id>
          </element-citation>
        </ref>
        <ref id="article-67758.r13">
          <label>13</label>
          <element-citation publication-type="book">
            <person-group person-group-type="author">
              <name>
                <surname>Nakashima</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Bordoni</surname>
                <given-names>B</given-names>
              </name>
            </person-group>
            <chapter-title>Anatomy, Abdomen and Pelvis: Hepatoduodenal Ligament</chapter-title>
            <source>StatPearls [Internet]</source>
            <publisher-name>StatPearls Publishing</publisher-name>
            <publisher-loc>Treasure Island (FL)</publisher-loc>
            <year>2022</year>
            <month>10</month>
            <day>31</day>
            <pub-id pub-id-type="pmid">32119375</pub-id>
          </element-citation>
        </ref>
        <ref id="article-67758.r14">
          <label>14</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Schmidt</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Demartines</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Soler</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Schnyder</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Denys</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>Portal vein normal anatomy and variants: implication for liver surgery and portal vein embolization.</article-title>
            <source>Semin Intervent Radiol</source>
            <year>2008</year>
            <month>Jun</month>
            <volume>25</volume>
            <issue>2</issue>
            <fpage>86</fpage>
            <page-range>86-91</page-range>
            <pub-id pub-id-type="pmid">21326549</pub-id>
          </element-citation>
        </ref>
        <ref id="article-67758.r15">
          <label>15</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Eipel</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Abshagen</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Vollmar</surname>
                <given-names>B</given-names>
              </name>
            </person-group>
            <article-title>Regulation of hepatic blood flow: the hepatic arterial buffer response revisited.</article-title>
            <source>World J Gastroenterol</source>
            <year>2010</year>
            <month>Dec</month>
            <day>28</day>
            <volume>16</volume>
            <issue>48</issue>
            <fpage>6046</fpage>
            <page-range>6046-57</page-range>
            <pub-id pub-id-type="pmid">21182219</pub-id>
          </element-citation>
        </ref>
        <ref id="article-67758.r16">
          <label>16</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Mi&#x000f1;ano</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Garcia-Tsao</surname>
                <given-names>G</given-names>
              </name>
            </person-group>
            <article-title>Clinical pharmacology of portal hypertension.</article-title>
            <source>Gastroenterol Clin North Am</source>
            <year>2010</year>
            <month>Sep</month>
            <volume>39</volume>
            <issue>3</issue>
            <fpage>681</fpage>
            <page-range>681-95</page-range>
            <pub-id pub-id-type="pmid">20951924</pub-id>
          </element-citation>
        </ref>
        <ref id="article-67758.r17">
          <label>17</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kennedy</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Bane</surname>
                <given-names>O</given-names>
              </name>
              <name>
                <surname>Hectors</surname>
                <given-names>SJ</given-names>
              </name>
              <name>
                <surname>Fischman</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Schiano</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Lewis</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Taouli</surname>
                <given-names>B</given-names>
              </name>
            </person-group>
            <article-title>Noninvasive imaging assessment of portal hypertension.</article-title>
            <source>Abdom Radiol (NY)</source>
            <year>2020</year>
            <month>Nov</month>
            <volume>45</volume>
            <issue>11</issue>
            <fpage>3473</fpage>
            <page-range>3473-3495</page-range>
            <pub-id pub-id-type="pmid">32926209</pub-id>
          </element-citation>
        </ref>
        <ref id="article-67758.r18">
          <label>18</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Naschitz</surname>
                <given-names>JE</given-names>
              </name>
              <name>
                <surname>Slobodin</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Lewis</surname>
                <given-names>RJ</given-names>
              </name>
              <name>
                <surname>Zuckerman</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Yeshurun</surname>
                <given-names>D</given-names>
              </name>
            </person-group>
            <article-title>Heart diseases affecting the liver and liver diseases affecting the heart.</article-title>
            <source>Am Heart J</source>
            <year>2000</year>
            <month>Jul</month>
            <volume>140</volume>
            <issue>1</issue>
            <fpage>111</fpage>
            <page-range>111-20</page-range>
            <pub-id pub-id-type="pmid">10874271</pub-id>
          </element-citation>
        </ref>
        <ref id="article-67758.r19">
          <label>19</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Wells</surname>
                <given-names>ML</given-names>
              </name>
              <name>
                <surname>Fenstad</surname>
                <given-names>ER</given-names>
              </name>
              <name>
                <surname>Poterucha</surname>
                <given-names>JT</given-names>
              </name>
              <name>
                <surname>Hough</surname>
                <given-names>DM</given-names>
              </name>
              <name>
                <surname>Young</surname>
                <given-names>PM</given-names>
              </name>
              <name>
                <surname>Araoz</surname>
                <given-names>PA</given-names>
              </name>
              <name>
                <surname>Ehman</surname>
                <given-names>RL</given-names>
              </name>
              <name>
                <surname>Venkatesh</surname>
                <given-names>SK</given-names>
              </name>
            </person-group>
            <article-title>Imaging Findings of Congestive Hepatopathy.</article-title>
            <source>Radiographics</source>
            <year>2016</year>
            <season>Jul-Aug</season>
            <volume>36</volume>
            <issue>4</issue>
            <fpage>1024</fpage>
            <page-range>1024-37</page-range>
            <pub-id pub-id-type="pmid">27284758</pub-id>
          </element-citation>
        </ref>
        <ref id="article-67758.r20">
          <label>20</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Afif</surname>
                <given-names>AM</given-names>
              </name>
              <name>
                <surname>Chang</surname>
                <given-names>JP</given-names>
              </name>
              <name>
                <surname>Wang</surname>
                <given-names>YY</given-names>
              </name>
              <name>
                <surname>Lau</surname>
                <given-names>SD</given-names>
              </name>
              <name>
                <surname>Deng</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Goh</surname>
                <given-names>SY</given-names>
              </name>
              <name>
                <surname>Pwint</surname>
                <given-names>MK</given-names>
              </name>
              <name>
                <surname>Ooi</surname>
                <given-names>CC</given-names>
              </name>
              <name>
                <surname>Venkatanarasimha</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Lo</surname>
                <given-names>RH</given-names>
              </name>
            </person-group>
            <article-title>A sonographic Doppler study of the hepatic vein, portal vein and hepatic artery in liver cirrhosis: Correlation of hepatic hemodynamics with clinical Child Pugh score in Singapore.</article-title>
            <source>Ultrasound</source>
            <year>2017</year>
            <month>Nov</month>
            <volume>25</volume>
            <issue>4</issue>
            <fpage>213</fpage>
            <page-range>213-221</page-range>
            <pub-id pub-id-type="pmid">29163657</pub-id>
          </element-citation>
        </ref>
        <ref id="article-67758.r21">
          <label>21</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Desautels</surname>
                <given-names>CN</given-names>
              </name>
              <name>
                <surname>Tierney</surname>
                <given-names>DM</given-names>
              </name>
              <name>
                <surname>Rossi</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Rosborough</surname>
                <given-names>TK</given-names>
              </name>
            </person-group>
            <article-title>Case report: an unrecognized etiology of transient gallbladder pain in heart failure diagnosed with internist-performed point-of-care ultrasound.</article-title>
            <source>Crit Ultrasound J</source>
            <year>2015</year>
            <volume>7</volume>
            <fpage>2</fpage>
            <pub-id pub-id-type="pmid">25852843</pub-id>
          </element-citation>
        </ref>
        <ref id="article-67758.r22">
          <label>22</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Teefey</surname>
                <given-names>SA</given-names>
              </name>
              <name>
                <surname>Baron</surname>
                <given-names>RL</given-names>
              </name>
              <name>
                <surname>Bigler</surname>
                <given-names>SA</given-names>
              </name>
            </person-group>
            <article-title>Sonography of the gallbladder: significance of striated (layered) thickening of the gallbladder wall.</article-title>
            <source>AJR Am J Roentgenol</source>
            <year>1991</year>
            <month>May</month>
            <volume>156</volume>
            <issue>5</issue>
            <fpage>945</fpage>
            <page-range>945-7</page-range>
            <pub-id pub-id-type="pmid">2017956</pub-id>
          </element-citation>
        </ref>
        <ref id="article-67758.r23">
          <label>23</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Smith</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Baumgartner</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Bositis</surname>
                <given-names>C</given-names>
              </name>
            </person-group>
            <article-title>Cirrhosis: Diagnosis and Management.</article-title>
            <source>Am Fam Physician</source>
            <year>2019</year>
            <month>Dec</month>
            <day>15</day>
            <volume>100</volume>
            <issue>12</issue>
            <fpage>759</fpage>
            <page-range>759-770</page-range>
            <pub-id pub-id-type="pmid">31845776</pub-id>
          </element-citation>
        </ref>
        <ref id="article-67758.r24">
          <label>24</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kartalis</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Brehmer</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Loizou</surname>
                <given-names>L</given-names>
              </name>
            </person-group>
            <article-title>Multi-detector CT: Liver protocol and recent developments.</article-title>
            <source>Eur J Radiol</source>
            <year>2017</year>
            <month>Dec</month>
            <volume>97</volume>
            <fpage>101</fpage>
            <page-range>101-109</page-range>
            <pub-id pub-id-type="pmid">29153359</pub-id>
          </element-citation>
        </ref>
        <ref id="article-67758.r25">
          <label>25</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kim</surname>
                <given-names>SH</given-names>
              </name>
              <name>
                <surname>Kamaya</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Willmann</surname>
                <given-names>JK</given-names>
              </name>
            </person-group>
            <article-title>CT perfusion of the liver: principles and applications in oncology.</article-title>
            <source>Radiology</source>
            <year>2014</year>
            <month>Aug</month>
            <volume>272</volume>
            <issue>2</issue>
            <fpage>322</fpage>
            <page-range>322-44</page-range>
            <pub-id pub-id-type="pmid">25058132</pub-id>
          </element-citation>
        </ref>
        <ref id="article-67758.r26">
          <label>26</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Sween</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Samar</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Binu</surname>
                <given-names>SM</given-names>
              </name>
            </person-group>
            <article-title>Triple-phase MDCT of liver: Scan protocol modification to obtain optimal vascular and lesional contrast.</article-title>
            <source>Indian J Radiol Imaging</source>
            <year>2018</year>
            <season>Jul-Sep</season>
            <volume>28</volume>
            <issue>3</issue>
            <fpage>315</fpage>
            <page-range>315-319</page-range>
            <pub-id pub-id-type="pmid">30319208</pub-id>
          </element-citation>
        </ref>
        <ref id="article-67758.r27">
          <label>27</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Hennedige</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Venkatesh</surname>
                <given-names>SK</given-names>
              </name>
            </person-group>
            <article-title>Imaging of hepatocellular carcinoma: diagnosis, staging and treatment monitoring.</article-title>
            <source>Cancer Imaging</source>
            <year>2013</year>
            <month>Feb</month>
            <day>08</day>
            <volume>12</volume>
            <issue>3</issue>
            <fpage>530</fpage>
            <page-range>530-47</page-range>
            <pub-id pub-id-type="pmid">23400006</pub-id>
          </element-citation>
        </ref>
        <ref id="article-67758.r28">
          <label>28</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kojiro</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Roskams</surname>
                <given-names>T</given-names>
              </name>
            </person-group>
            <article-title>Early hepatocellular carcinoma and dysplastic nodules.</article-title>
            <source>Semin Liver Dis</source>
            <year>2005</year>
            <volume>25</volume>
            <issue>2</issue>
            <fpage>133</fpage>
            <page-range>133-42</page-range>
            <pub-id pub-id-type="pmid">15918142</pub-id>
          </element-citation>
        </ref>
        <ref id="article-67758.r29">
          <label>29</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Ringe</surname>
                <given-names>KI</given-names>
              </name>
              <name>
                <surname>Wacker</surname>
                <given-names>F</given-names>
              </name>
            </person-group>
            <article-title>Radiological diagnosis in cholangiocarcinoma: Application of computed tomography, magnetic resonance imaging, and positron emission tomography.</article-title>
            <source>Best Pract Res Clin Gastroenterol</source>
            <year>2015</year>
            <month>Apr</month>
            <volume>29</volume>
            <issue>2</issue>
            <fpage>253</fpage>
            <page-range>253-65</page-range>
            <pub-id pub-id-type="pmid">25966426</pub-id>
          </element-citation>
        </ref>
        <ref id="article-67758.r30">
          <label>30</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Wu</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Sharma</surname>
                <given-names>PG</given-names>
              </name>
              <name>
                <surname>Grajo</surname>
                <given-names>JR</given-names>
              </name>
            </person-group>
            <article-title>The Echogenic Liver: Steatosis and Beyond.</article-title>
            <source>Ultrasound Q</source>
            <year>2020</year>
            <month>Sep</month>
            <day>21</day>
            <volume>37</volume>
            <issue>4</issue>
            <fpage>308</fpage>
            <page-range>308-314</page-range>
            <pub-id pub-id-type="pmid">32956242</pub-id>
          </element-citation>
        </ref>
        <ref id="article-67758.r31">
          <label>31</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Ahmed</surname>
                <given-names>AM</given-names>
              </name>
              <name>
                <surname>Ebid</surname>
                <given-names>ME</given-names>
              </name>
              <name>
                <surname>Ajlan</surname>
                <given-names>AM</given-names>
              </name>
              <name>
                <surname>Al-Mallah</surname>
                <given-names>MH</given-names>
              </name>
            </person-group>
            <article-title>Low-dose attenuation correction in diagnosis of non-alcoholic fatty liver disease.</article-title>
            <source>Abdom Radiol (NY)</source>
            <year>2017</year>
            <month>Oct</month>
            <volume>42</volume>
            <issue>10</issue>
            <fpage>2454</fpage>
            <page-range>2454-2459</page-range>
            <pub-id pub-id-type="pmid">28470401</pub-id>
          </element-citation>
        </ref>
        <ref id="article-67758.r32">
          <label>32</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Hamer</surname>
                <given-names>OW</given-names>
              </name>
              <name>
                <surname>Aguirre</surname>
                <given-names>DA</given-names>
              </name>
              <name>
                <surname>Casola</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Lavine</surname>
                <given-names>JE</given-names>
              </name>
              <name>
                <surname>Woenckhaus</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Sirlin</surname>
                <given-names>CB</given-names>
              </name>
            </person-group>
            <article-title>Fatty liver: imaging patterns and pitfalls.</article-title>
            <source>Radiographics</source>
            <year>2006</year>
            <season>Nov-Dec</season>
            <volume>26</volume>
            <issue>6</issue>
            <fpage>1637</fpage>
            <page-range>1637-53</page-range>
            <pub-id pub-id-type="pmid">17102041</pub-id>
          </element-citation>
        </ref>
        <ref id="article-67758.r33">
          <label>33</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kalra</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Duseja</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Das</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Dhiman</surname>
                <given-names>RK</given-names>
              </name>
              <name>
                <surname>Virmani</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Chawla</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Singh</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Khandelwal</surname>
                <given-names>N</given-names>
              </name>
            </person-group>
            <article-title>Chemical shift magnetic resonance imaging is helpful in detecting hepatic steatosis but not fibrosis in patients with nonalcoholic fatty liver disease (NAFLD).</article-title>
            <source>Ann Hepatol</source>
            <year>2009</year>
            <season>Jan-Mar</season>
            <volume>8</volume>
            <issue>1</issue>
            <fpage>21</fpage>
            <page-range>21-5</page-range>
            <pub-id pub-id-type="pmid">19221529</pub-id>
          </element-citation>
        </ref>
        <ref id="article-67758.r34">
          <label>34</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Taouli</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Ehman</surname>
                <given-names>RL</given-names>
              </name>
              <name>
                <surname>Reeder</surname>
                <given-names>SB</given-names>
              </name>
            </person-group>
            <article-title>Advanced MRI methods for assessment of chronic liver disease.</article-title>
            <source>AJR Am J Roentgenol</source>
            <year>2009</year>
            <month>Jul</month>
            <volume>193</volume>
            <issue>1</issue>
            <fpage>14</fpage>
            <page-range>14-27</page-range>
            <pub-id pub-id-type="pmid">19542391</pub-id>
          </element-citation>
        </ref>
        <ref id="article-67758.r35">
          <label>35</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Yoshikawa</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Matsui</surname>
                <given-names>O</given-names>
              </name>
              <name>
                <surname>Takashima</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Sugiura</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Katayama</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Nishida</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Tsuji</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>Focal fatty change of the liver adjacent to the falciform ligament: CT and sonographic findings in five surgically confirmed cases.</article-title>
            <source>AJR Am J Roentgenol</source>
            <year>1987</year>
            <month>Sep</month>
            <volume>149</volume>
            <issue>3</issue>
            <fpage>491</fpage>
            <page-range>491-4</page-range>
            <pub-id pub-id-type="pmid">3303875</pub-id>
          </element-citation>
        </ref>
        <ref id="article-67758.r36">
          <label>36</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>D&#x000e9;carie</surname>
                <given-names>PO</given-names>
              </name>
              <name>
                <surname>Lepanto</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Billiard</surname>
                <given-names>JS</given-names>
              </name>
              <name>
                <surname>Olivi&#x000e9;</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Murphy-Lavall&#x000e9;e</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Kauffmann</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Tang</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>Fatty liver deposition and sparing: a pictorial review.</article-title>
            <source>Insights Imaging</source>
            <year>2011</year>
            <month>Oct</month>
            <volume>2</volume>
            <issue>5</issue>
            <fpage>533</fpage>
            <page-range>533-538</page-range>
            <pub-id pub-id-type="pmid">22347973</pub-id>
          </element-citation>
        </ref>
        <ref id="article-67758.r37">
          <label>37</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Bader</surname>
                <given-names>TR</given-names>
              </name>
              <name>
                <surname>Braga</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Semelka</surname>
                <given-names>RC</given-names>
              </name>
            </person-group>
            <article-title>Exophytic benign tumors of the liver: appearance on MRI.</article-title>
            <source>Magn Reson Imaging</source>
            <year>2001</year>
            <month>Jun</month>
            <volume>19</volume>
            <issue>5</issue>
            <fpage>623</fpage>
            <page-range>623-8</page-range>
            <pub-id pub-id-type="pmid">11672619</pub-id>
          </element-citation>
        </ref>
        <ref id="article-67758.r38">
          <label>38</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>&#x000d6;zcan</surname>
                <given-names>HN</given-names>
              </name>
              <name>
                <surname>Halilo&#x0011f;lu</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>S&#x000f6;kmens&#x000fc;er</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Akata</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>&#x000d6;zmen</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Kar&#x000e7;aalt&#x00131;ncaba</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>Imaging for abdominal involvement in amyloidosis.</article-title>
            <source>Diagn Interv Radiol</source>
            <year>2017</year>
            <season>Jul-Aug</season>
            <volume>23</volume>
            <issue>4</issue>
            <fpage>282</fpage>
            <page-range>282-285</page-range>
            <pub-id pub-id-type="pmid">28498108</pub-id>
          </element-citation>
        </ref>
        <ref id="article-67758.r39">
          <label>39</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Schilsky</surname>
                <given-names>ML</given-names>
              </name>
            </person-group>
            <article-title>Wilson Disease: Diagnosis, Treatment, and Follow-up.</article-title>
            <source>Clin Liver Dis</source>
            <year>2017</year>
            <month>Nov</month>
            <volume>21</volume>
            <issue>4</issue>
            <fpage>755</fpage>
            <page-range>755-767</page-range>
            <pub-id pub-id-type="pmid">28987261</pub-id>
          </element-citation>
        </ref>
        <ref id="article-67758.r40">
          <label>40</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Cordella</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Bertolini</surname>
                <given-names>G</given-names>
              </name>
            </person-group>
            <article-title>Multiphase multidetector-row CT reveals different patterns of hepatic portal venous gas and pneumobilia.</article-title>
            <source>Vet Radiol Ultrasound</source>
            <year>2021</year>
            <month>Jan</month>
            <volume>62</volume>
            <issue>1</issue>
            <fpage>68</fpage>
            <page-range>68-75</page-range>
            <pub-id pub-id-type="pmid">33245597</pub-id>
          </element-citation>
        </ref>
        <ref id="article-67758.r41">
          <label>41</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Abboud</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>El Hachem</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Yazbeck</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Doumit</surname>
                <given-names>C</given-names>
              </name>
            </person-group>
            <article-title>Hepatic portal venous gas: physiopathology, etiology, prognosis and treatment.</article-title>
            <source>World J Gastroenterol</source>
            <year>2009</year>
            <month>Aug</month>
            <day>07</day>
            <volume>15</volume>
            <issue>29</issue>
            <fpage>3585</fpage>
            <page-range>3585-90</page-range>
            <pub-id pub-id-type="pmid">19653334</pub-id>
          </element-citation>
        </ref>
        <ref id="article-67758.r42">
          <label>42</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Sherman</surname>
                <given-names>SC</given-names>
              </name>
              <name>
                <surname>Tran</surname>
                <given-names>H</given-names>
              </name>
            </person-group>
            <article-title>Pneumobilia: benign or life-threatening.</article-title>
            <source>J Emerg Med</source>
            <year>2006</year>
            <month>Feb</month>
            <volume>30</volume>
            <issue>2</issue>
            <fpage>147</fpage>
            <page-range>147-53</page-range>
            <pub-id pub-id-type="pmid">16567248</pub-id>
          </element-citation>
        </ref>
        <ref id="article-67758.r43">
          <label>43</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Khim</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Em</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Mo</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Townell</surname>
                <given-names>N</given-names>
              </name>
            </person-group>
            <article-title>Liver abscess: diagnostic and management issues found in the low resource setting.</article-title>
            <source>Br Med Bull</source>
            <year>2019</year>
            <month>Dec</month>
            <day>11</day>
            <volume>132</volume>
            <issue>1</issue>
            <fpage>45</fpage>
            <page-range>45-52</page-range>
            <pub-id pub-id-type="pmid">31836890</pub-id>
          </element-citation>
        </ref>
        <ref id="article-67758.r44">
          <label>44</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>M&#x000e9;ndez</surname>
                <given-names>RJ</given-names>
              </name>
              <name>
                <surname>Schiebler</surname>
                <given-names>ML</given-names>
              </name>
              <name>
                <surname>Outwater</surname>
                <given-names>EK</given-names>
              </name>
              <name>
                <surname>Kressel</surname>
                <given-names>HY</given-names>
              </name>
            </person-group>
            <article-title>Hepatic abscesses: MR imaging findings.</article-title>
            <source>Radiology</source>
            <year>1994</year>
            <month>Feb</month>
            <volume>190</volume>
            <issue>2</issue>
            <fpage>431</fpage>
            <page-range>431-6</page-range>
            <pub-id pub-id-type="pmid">8284394</pub-id>
          </element-citation>
        </ref>
        <ref id="article-67758.r45">
          <label>45</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Mortel&#x000e9;</surname>
                <given-names>KJ</given-names>
              </name>
              <name>
                <surname>Segatto</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Ros</surname>
                <given-names>PR</given-names>
              </name>
            </person-group>
            <article-title>The infected liver: radiologic-pathologic correlation.</article-title>
            <source>Radiographics</source>
            <year>2004</year>
            <season>Jul-Aug</season>
            <volume>24</volume>
            <issue>4</issue>
            <fpage>937</fpage>
            <page-range>937-55</page-range>
            <pub-id pub-id-type="pmid">15256619</pub-id>
          </element-citation>
        </ref>
        <ref id="article-67758.r46">
          <label>46</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Masood</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Sallah</surname>
                <given-names>S</given-names>
              </name>
            </person-group>
            <article-title>Chronic disseminated candidiasis in patients with acute leukemia: emphasis on diagnostic definition and treatment.</article-title>
            <source>Leuk Res</source>
            <year>2005</year>
            <month>May</month>
            <volume>29</volume>
            <issue>5</issue>
            <fpage>493</fpage>
            <page-range>493-501</page-range>
            <pub-id pub-id-type="pmid">15755501</pub-id>
          </element-citation>
        </ref>
        <ref id="article-67758.r47">
          <label>47</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Lima</surname>
                <given-names>PH</given-names>
              </name>
              <name>
                <surname>Fan</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>B&#x000e9;rub&#x000e9;</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Cerny</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Olivi&#x000e9;</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Giard</surname>
                <given-names>JM</given-names>
              </name>
              <name>
                <surname>Beauchemin</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Tang</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>Cost-Utility Analysis of Imaging for Surveillance and Diagnosis of Hepatocellular Carcinoma.</article-title>
            <source>AJR Am J Roentgenol</source>
            <year>2019</year>
            <month>Jul</month>
            <volume>213</volume>
            <issue>1</issue>
            <fpage>17</fpage>
            <page-range>17-25</page-range>
            <pub-id pub-id-type="pmid">30995098</pub-id>
          </element-citation>
        </ref>
        <ref id="article-67758.r48">
          <label>48</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Coenegrachts</surname>
                <given-names>K</given-names>
              </name>
            </person-group>
            <article-title>Magnetic resonance imaging of the liver: New imaging strategies for evaluating focal liver lesions.</article-title>
            <source>World J Radiol</source>
            <year>2009</year>
            <month>Dec</month>
            <day>31</day>
            <volume>1</volume>
            <issue>1</issue>
            <fpage>72</fpage>
            <page-range>72-85</page-range>
            <pub-id pub-id-type="pmid">21160723</pub-id>
          </element-citation>
        </ref>
        <ref id="article-67758.r49">
          <label>49</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>O'Neill</surname>
                <given-names>EK</given-names>
              </name>
              <name>
                <surname>Cogley</surname>
                <given-names>JR</given-names>
              </name>
              <name>
                <surname>Miller</surname>
                <given-names>FH</given-names>
              </name>
            </person-group>
            <article-title>The ins and outs of liver imaging.</article-title>
            <source>Clin Liver Dis</source>
            <year>2015</year>
            <month>Feb</month>
            <volume>19</volume>
            <issue>1</issue>
            <fpage>99</fpage>
            <page-range>99-121</page-range>
            <pub-id pub-id-type="pmid">25454299</pub-id>
          </element-citation>
        </ref>
        <ref id="article-67758.r50">
          <label>50</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Grazioli</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Bondioni</surname>
                <given-names>MP</given-names>
              </name>
              <name>
                <surname>Haradome</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Motosugi</surname>
                <given-names>U</given-names>
              </name>
              <name>
                <surname>Tinti</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Frittoli</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Gambarini</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Donato</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Colagrande</surname>
                <given-names>S</given-names>
              </name>
            </person-group>
            <article-title>Hepatocellular adenoma and focal nodular hyperplasia: value of gadoxetic acid-enhanced MR imaging in differential diagnosis.</article-title>
            <source>Radiology</source>
            <year>2012</year>
            <month>Feb</month>
            <volume>262</volume>
            <issue>2</issue>
            <fpage>520</fpage>
            <page-range>520-9</page-range>
            <pub-id pub-id-type="pmid">22282184</pub-id>
          </element-citation>
        </ref>
        <ref id="article-67758.r51">
          <label>51</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Manduca</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Bayly</surname>
                <given-names>PJ</given-names>
              </name>
              <name>
                <surname>Ehman</surname>
                <given-names>RL</given-names>
              </name>
              <name>
                <surname>Kolipaka</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Royston</surname>
                <given-names>TJ</given-names>
              </name>
              <name>
                <surname>Sack</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Sinkus</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Van Beers</surname>
                <given-names>BE</given-names>
              </name>
            </person-group>
            <article-title>MR elastography: Principles, guidelines, and terminology.</article-title>
            <source>Magn Reson Med</source>
            <year>2021</year>
            <month>May</month>
            <volume>85</volume>
            <issue>5</issue>
            <fpage>2377</fpage>
            <page-range>2377-2390</page-range>
            <pub-id pub-id-type="pmid">33296103</pub-id>
          </element-citation>
        </ref>
        <ref id="article-67758.r52">
          <label>52</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Shankaran</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Gill</surname>
                <given-names>HH</given-names>
              </name>
              <name>
                <surname>Desai</surname>
                <given-names>HG</given-names>
              </name>
            </person-group>
            <article-title>Genetic hemochromatosis presenting as asymptomatic hepatomegaly.</article-title>
            <source>Indian J Gastroenterol</source>
            <year>1994</year>
            <month>Apr</month>
            <volume>13</volume>
            <issue>2</issue>
            <fpage>64</fpage>
            <page-range>64-5</page-range>
            <pub-id pub-id-type="pmid">8206540</pub-id>
          </element-citation>
        </ref>
        <ref id="article-67758.r53">
          <label>53</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Labranche</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Gilbert</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Cerny</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Vu</surname>
                <given-names>KN</given-names>
              </name>
              <name>
                <surname>Souli&#x000e8;res</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Olivi&#x000e9;</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Billiard</surname>
                <given-names>JS</given-names>
              </name>
              <name>
                <surname>Yokoo</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Tang</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>Liver Iron Quantification with MR Imaging: A Primer for Radiologists.</article-title>
            <source>Radiographics</source>
            <year>2018</year>
            <season>Mar-Apr</season>
            <volume>38</volume>
            <issue>2</issue>
            <fpage>392</fpage>
            <page-range>392-412</page-range>
            <pub-id pub-id-type="pmid">29528818</pub-id>
          </element-citation>
        </ref>
        <ref id="article-67758.r54">
          <label>54</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Klotz</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Montoriol</surname>
                <given-names>PF</given-names>
              </name>
              <name>
                <surname>Da Ines</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Petitcolin</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Joubert-Zakeyh</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Garcier</surname>
                <given-names>JM</given-names>
              </name>
            </person-group>
            <article-title>Hepatic haemangioma: common and uncommon imaging features.</article-title>
            <source>Diagn Interv Imaging</source>
            <year>2013</year>
            <month>Sep</month>
            <volume>94</volume>
            <issue>9</issue>
            <fpage>849</fpage>
            <page-range>849-59</page-range>
            <pub-id pub-id-type="pmid">23796395</pub-id>
          </element-citation>
        </ref>
        <ref id="article-67758.r55">
          <label>55</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Hoekstra</surname>
                <given-names>LT</given-names>
              </name>
              <name>
                <surname>Bieze</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Erdogan</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Roelofs</surname>
                <given-names>JJ</given-names>
              </name>
              <name>
                <surname>Beuers</surname>
                <given-names>UH</given-names>
              </name>
              <name>
                <surname>van Gulik</surname>
                <given-names>TM</given-names>
              </name>
            </person-group>
            <article-title>Management of giant liver hemangiomas: an update.</article-title>
            <source>Expert Rev Gastroenterol Hepatol</source>
            <year>2013</year>
            <month>Mar</month>
            <volume>7</volume>
            <issue>3</issue>
            <fpage>263</fpage>
            <page-range>263-8</page-range>
            <pub-id pub-id-type="pmid">23445235</pub-id>
          </element-citation>
        </ref>
        <ref id="article-67758.r56">
          <label>56</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Mamone</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Di Piazza</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Carollo</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Cannataci</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Cortis</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Bartolotta</surname>
                <given-names>TV</given-names>
              </name>
              <name>
                <surname>Miraglia</surname>
                <given-names>R</given-names>
              </name>
            </person-group>
            <article-title>Imaging of hepatic hemangioma: from A to Z.</article-title>
            <source>Abdom Radiol (NY)</source>
            <year>2020</year>
            <month>Mar</month>
            <volume>45</volume>
            <issue>3</issue>
            <fpage>672</fpage>
            <page-range>672-691</page-range>
            <pub-id pub-id-type="pmid">31686179</pub-id>
          </element-citation>
        </ref>
        <ref id="article-67758.r57">
          <label>57</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Hussain</surname>
                <given-names>SM</given-names>
              </name>
              <name>
                <surname>Terkivatan</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Zondervan</surname>
                <given-names>PE</given-names>
              </name>
              <name>
                <surname>Lanjouw</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>de Rave</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Ijzermans</surname>
                <given-names>JN</given-names>
              </name>
              <name>
                <surname>de Man</surname>
                <given-names>RA</given-names>
              </name>
            </person-group>
            <article-title>Focal nodular hyperplasia: findings at state-of-the-art MR imaging, US, CT, and pathologic analysis.</article-title>
            <source>Radiographics</source>
            <year>2004</year>
            <season>Jan-Feb</season>
            <volume>24</volume>
            <issue>1</issue>
            <fpage>3</fpage>
            <page-range>3-17; discussion 18-9</page-range>
            <pub-id pub-id-type="pmid">14730031</pub-id>
          </element-citation>
        </ref>
        <ref id="article-67758.r58">
          <label>58</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Haring</surname>
                <given-names>MPD</given-names>
              </name>
              <name>
                <surname>Gouw</surname>
                <given-names>ASH</given-names>
              </name>
              <name>
                <surname>de Haas</surname>
                <given-names>RJ</given-names>
              </name>
              <name>
                <surname>Cuperus</surname>
                <given-names>FJC</given-names>
              </name>
              <name>
                <surname>de Jong</surname>
                <given-names>KP</given-names>
              </name>
              <name>
                <surname>de Meijer</surname>
                <given-names>VE</given-names>
              </name>
            </person-group>
            <article-title>The effect of oral contraceptive pill cessation on hepatocellular adenoma diameter: A retrospective cohort study.</article-title>
            <source>Liver Int</source>
            <year>2019</year>
            <month>May</month>
            <volume>39</volume>
            <issue>5</issue>
            <fpage>905</fpage>
            <page-range>905-913</page-range>
            <pub-id pub-id-type="pmid">30773766</pub-id>
          </element-citation>
        </ref>
        <ref id="article-67758.r59">
          <label>59</label>
          <element-citation publication-type="book">
            <person-group person-group-type="author">
              <name>
                <surname>Shreenath</surname>
                <given-names>AP</given-names>
              </name>
              <name>
                <surname>Grant</surname>
                <given-names>LM</given-names>
              </name>
              <name>
                <surname>Kahloon</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <chapter-title>Hepatocellular Adenoma</chapter-title>
            <source>StatPearls [Internet]</source>
            <publisher-name>StatPearls Publishing</publisher-name>
            <publisher-loc>Treasure Island (FL)</publisher-loc>
            <year>2024</year>
            <month>5</month>
            <day>6</day>
            <pub-id pub-id-type="pmid">30020636</pub-id>
          </element-citation>
        </ref>
        <ref id="article-67758.r60">
          <label>60</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Micchelli</surname>
                <given-names>ST</given-names>
              </name>
              <name>
                <surname>Vivekanandan</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Boitnott</surname>
                <given-names>JK</given-names>
              </name>
              <name>
                <surname>Pawlik</surname>
                <given-names>TM</given-names>
              </name>
              <name>
                <surname>Choti</surname>
                <given-names>MA</given-names>
              </name>
              <name>
                <surname>Torbenson</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>Malignant transformation of hepatic adenomas.</article-title>
            <source>Mod Pathol</source>
            <year>2008</year>
            <month>Apr</month>
            <volume>21</volume>
            <issue>4</issue>
            <fpage>491</fpage>
            <page-range>491-7</page-range>
            <pub-id pub-id-type="pmid">18246041</pub-id>
          </element-citation>
        </ref>
        <ref id="article-67758.r61">
          <label>61</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Nasser</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Affonso</surname>
                <given-names>BB</given-names>
              </name>
              <name>
                <surname>Galastri</surname>
                <given-names>FL</given-names>
              </name>
              <name>
                <surname>Odisio</surname>
                <given-names>BC</given-names>
              </name>
              <name>
                <surname>Garcia</surname>
                <given-names>RG</given-names>
              </name>
            </person-group>
            <article-title>Minimally invasive treatment of hepatic adenoma in special cases.</article-title>
            <source>Einstein (Sao Paulo)</source>
            <year>2013</year>
            <month>Dec</month>
            <volume>11</volume>
            <issue>4</issue>
            <fpage>524</fpage>
            <page-range>524-7</page-range>
            <pub-id pub-id-type="pmid">24488396</pub-id>
          </element-citation>
        </ref>
        <ref id="article-67758.r62">
          <label>62</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Seo</surname>
                <given-names>JK</given-names>
              </name>
              <name>
                <surname>Kim</surname>
                <given-names>SH</given-names>
              </name>
              <name>
                <surname>Lee</surname>
                <given-names>SH</given-names>
              </name>
              <name>
                <surname>Park</surname>
                <given-names>JK</given-names>
              </name>
              <name>
                <surname>Woo</surname>
                <given-names>SM</given-names>
              </name>
              <name>
                <surname>Jeong</surname>
                <given-names>JB</given-names>
              </name>
              <name>
                <surname>Hwang</surname>
                <given-names>JH</given-names>
              </name>
              <name>
                <surname>Ryu</surname>
                <given-names>JK</given-names>
              </name>
              <name>
                <surname>Kim</surname>
                <given-names>JW</given-names>
              </name>
              <name>
                <surname>Jeong</surname>
                <given-names>SH</given-names>
              </name>
              <name>
                <surname>Kim</surname>
                <given-names>YT</given-names>
              </name>
              <name>
                <surname>Yoon</surname>
                <given-names>YB</given-names>
              </name>
              <name>
                <surname>Lee</surname>
                <given-names>KU</given-names>
              </name>
              <name>
                <surname>Kim</surname>
                <given-names>SH</given-names>
              </name>
              <name>
                <surname>Kim</surname>
                <given-names>MA</given-names>
              </name>
            </person-group>
            <article-title>Appropriate diagnosis of biliary cystic tumors: comparison with atypical hepatic simple cysts.</article-title>
            <source>Eur J Gastroenterol Hepatol</source>
            <year>2010</year>
            <month>Aug</month>
            <volume>22</volume>
            <issue>8</issue>
            <fpage>989</fpage>
            <page-range>989-96</page-range>
            <pub-id pub-id-type="pmid">20300006</pub-id>
          </element-citation>
        </ref>
        <ref id="article-67758.r63">
          <label>63</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Asuquo</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Nwagbara</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Agbor</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Otobo</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Omotoso</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>Giant simple hepatic cyst: a case report and review of relevant literature.</article-title>
            <source>Afr Health Sci</source>
            <year>2015</year>
            <month>Mar</month>
            <volume>15</volume>
            <issue>1</issue>
            <fpage>293</fpage>
            <page-range>293-8</page-range>
            <pub-id pub-id-type="pmid">25834563</pub-id>
          </element-citation>
        </ref>
        <ref id="article-67758.r64">
          <label>64</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Anderson</surname>
                <given-names>MA</given-names>
              </name>
              <name>
                <surname>Dhami</surname>
                <given-names>RS</given-names>
              </name>
              <name>
                <surname>Fadzen</surname>
                <given-names>CM</given-names>
              </name>
              <name>
                <surname>Molina</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Taylor</surname>
                <given-names>MS</given-names>
              </name>
              <name>
                <surname>Deshpande</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Qadan</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Catalano</surname>
                <given-names>OA</given-names>
              </name>
              <name>
                <surname>Ferrone</surname>
                <given-names>CR</given-names>
              </name>
              <name>
                <surname>Mojtahed</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>CT and MRI features differentiating mucinous cystic neoplasms of the liver from pathologically simple cysts.</article-title>
            <source>Clin Imaging</source>
            <year>2021</year>
            <month>Aug</month>
            <volume>76</volume>
            <fpage>46</fpage>
            <page-range>46-52</page-range>
            <pub-id pub-id-type="pmid">33549919</pub-id>
          </element-citation>
        </ref>
        <ref id="article-67758.r65">
          <label>65</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Mizejewski</surname>
                <given-names>GJ</given-names>
              </name>
            </person-group>
            <article-title>Levels of alpha-fetoprotein during pregnancy and early infancy in normal and disease states.</article-title>
            <source>Obstet Gynecol Surv</source>
            <year>2003</year>
            <month>Dec</month>
            <volume>58</volume>
            <issue>12</issue>
            <fpage>804</fpage>
            <page-range>804-26</page-range>
            <pub-id pub-id-type="pmid">14668662</pub-id>
          </element-citation>
        </ref>
        <ref id="article-67758.r66">
          <label>66</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Arrieta</surname>
                <given-names>O</given-names>
              </name>
              <name>
                <surname>Cacho</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Morales-Espinosa</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Ruelas-Villavicencio</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Flores-Estrada</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Hern&#x000e1;ndez-Pedro</surname>
                <given-names>N</given-names>
              </name>
            </person-group>
            <article-title>The progressive elevation of alpha fetoprotein for the diagnosis of hepatocellular carcinoma in patients with liver cirrhosis.</article-title>
            <source>BMC Cancer</source>
            <year>2007</year>
            <month>Feb</month>
            <day>08</day>
            <volume>7</volume>
            <fpage>28</fpage>
            <pub-id pub-id-type="pmid">17288606</pub-id>
          </element-citation>
        </ref>
        <ref id="article-67758.r67">
          <label>67</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Numata</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Luo</surname>
                <given-names>W</given-names>
              </name>
              <name>
                <surname>Morimoto</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Kondo</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Kunishi</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Sasaki</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Nozaki</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Tanaka</surname>
                <given-names>K</given-names>
              </name>
            </person-group>
            <article-title>Contrast enhanced ultrasound of hepatocellular carcinoma.</article-title>
            <source>World J Radiol</source>
            <year>2010</year>
            <month>Feb</month>
            <day>28</day>
            <volume>2</volume>
            <issue>2</issue>
            <fpage>68</fpage>
            <page-range>68-82</page-range>
            <pub-id pub-id-type="pmid">21160920</pub-id>
          </element-citation>
        </ref>
        <ref id="article-67758.r68">
          <label>68</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Gupta</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Soundararajan</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Patel</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Kumar-M</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Sharma</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Kalra</surname>
                <given-names>N</given-names>
              </name>
            </person-group>
            <article-title>Abbreviated MRI for hepatocellular carcinoma screening: A systematic review and meta-analysis.</article-title>
            <source>J Hepatol</source>
            <year>2021</year>
            <month>Jul</month>
            <volume>75</volume>
            <issue>1</issue>
            <fpage>108</fpage>
            <page-range>108-119</page-range>
            <pub-id pub-id-type="pmid">33548385</pub-id>
          </element-citation>
        </ref>
        <ref id="article-67758.r69">
          <label>69</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Takayasu</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Furukawa</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Wakao</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Muramatsu</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Abe</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Terauchi</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Winter</surname>
                <given-names>TC</given-names>
              </name>
              <name>
                <surname>Sakamoto</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Hirohashi</surname>
                <given-names>S</given-names>
              </name>
            </person-group>
            <article-title>CT diagnosis of early hepatocellular carcinoma: sensitivity, findings, and CT-pathologic correlation.</article-title>
            <source>AJR Am J Roentgenol</source>
            <year>1995</year>
            <month>Apr</month>
            <volume>164</volume>
            <issue>4</issue>
            <fpage>885</fpage>
            <page-range>885-90</page-range>
            <pub-id pub-id-type="pmid">7726041</pub-id>
          </element-citation>
        </ref>
        <ref id="article-67758.r70">
          <label>70</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Willatt</surname>
                <given-names>JM</given-names>
              </name>
              <name>
                <surname>Hussain</surname>
                <given-names>HK</given-names>
              </name>
              <name>
                <surname>Adusumilli</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Marrero</surname>
                <given-names>JA</given-names>
              </name>
            </person-group>
            <article-title>MR Imaging of hepatocellular carcinoma in the cirrhotic liver: challenges and controversies.</article-title>
            <source>Radiology</source>
            <year>2008</year>
            <month>May</month>
            <volume>247</volume>
            <issue>2</issue>
            <fpage>311</fpage>
            <page-range>311-30</page-range>
            <pub-id pub-id-type="pmid">18430871</pub-id>
          </element-citation>
        </ref>
        <ref id="article-67758.r71">
          <label>71</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Bolog</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Andreisek</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Oancea</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Mangrau</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>CT and MR imaging of hepatocellular carcinoma.</article-title>
            <source>J Gastrointestin Liver Dis</source>
            <year>2011</year>
            <month>Jun</month>
            <volume>20</volume>
            <issue>2</issue>
            <fpage>181</fpage>
            <page-range>181-9</page-range>
            <pub-id pub-id-type="pmid">21725516</pub-id>
          </element-citation>
        </ref>
        <ref id="article-67758.r72">
          <label>72</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Ganeshan</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Szklaruk</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Kundra</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Kaseb</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Rashid</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Elsayes</surname>
                <given-names>KM</given-names>
              </name>
            </person-group>
            <article-title>Imaging features of fibrolamellar hepatocellular carcinoma.</article-title>
            <source>AJR Am J Roentgenol</source>
            <year>2014</year>
            <month>Mar</month>
            <volume>202</volume>
            <issue>3</issue>
            <fpage>544</fpage>
            <page-range>544-52</page-range>
            <pub-id pub-id-type="pmid">24555590</pub-id>
          </element-citation>
        </ref>
        <ref id="article-67758.r73">
          <label>73</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Namasivayam</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Martin</surname>
                <given-names>DR</given-names>
              </name>
              <name>
                <surname>Saini</surname>
                <given-names>S</given-names>
              </name>
            </person-group>
            <article-title>Imaging of liver metastases: MRI.</article-title>
            <source>Cancer Imaging</source>
            <year>2007</year>
            <volume>7</volume>
            <issue>1</issue>
            <fpage>2</fpage>
            <page-range>2-9</page-range>
            <pub-id pub-id-type="pmid">17293303</pub-id>
          </element-citation>
        </ref>
        <ref id="article-67758.r74">
          <label>74</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Phisalprapa</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Supakankunti</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Charatcharoenwitthaya</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Apisarnthanarak</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Charoensak</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Washirasaksiri</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Srivanichakorn</surname>
                <given-names>W</given-names>
              </name>
              <name>
                <surname>Chaiyakunapruk</surname>
                <given-names>N</given-names>
              </name>
            </person-group>
            <article-title>Cost-effectiveness analysis of ultrasonography screening for nonalcoholic fatty liver disease in metabolic syndrome patients.</article-title>
            <source>Medicine (Baltimore)</source>
            <year>2017</year>
            <month>Apr</month>
            <volume>96</volume>
            <issue>17</issue>
            <fpage>e6585</fpage>
            <pub-id pub-id-type="pmid">28445256</pub-id>
          </element-citation>
        </ref>
        <ref id="article-67758.r75">
          <label>75</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Minami</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Kudo</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>Hepatic malignancies: Correlation between sonographic findings and pathological features.</article-title>
            <source>World J Radiol</source>
            <year>2010</year>
            <month>Jul</month>
            <day>28</day>
            <volume>2</volume>
            <issue>7</issue>
            <fpage>249</fpage>
            <page-range>249-56</page-range>
            <pub-id pub-id-type="pmid">21160664</pub-id>
          </element-citation>
        </ref>
        <ref id="article-67758.r76">
          <label>76</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Bekker</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Ploem</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>de Jong</surname>
                <given-names>KP</given-names>
              </name>
            </person-group>
            <article-title>Early hepatic artery thrombosis after liver transplantation: a systematic review of the incidence, outcome and risk factors.</article-title>
            <source>Am J Transplant</source>
            <year>2009</year>
            <month>Apr</month>
            <volume>9</volume>
            <issue>4</issue>
            <fpage>746</fpage>
            <page-range>746-57</page-range>
            <pub-id pub-id-type="pmid">19298450</pub-id>
          </element-citation>
        </ref>
        <ref id="article-67758.r77">
          <label>77</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Strobel</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Seitz</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Blank</surname>
                <given-names>W</given-names>
              </name>
              <name>
                <surname>Schuler</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Dietrich</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>von Herbay</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Friedrich-Rust</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Kunze</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Becker</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Will</surname>
                <given-names>U</given-names>
              </name>
              <name>
                <surname>Kratzer</surname>
                <given-names>W</given-names>
              </name>
              <name>
                <surname>Albert</surname>
                <given-names>FW</given-names>
              </name>
              <name>
                <surname>Pachmann</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Dirks</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Strunk</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Greis</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Bernatik</surname>
                <given-names>T</given-names>
              </name>
            </person-group>
            <article-title>Contrast-enhanced ultrasound for the characterization of focal liver lesions--diagnostic accuracy in clinical practice (DEGUM multicenter trial).</article-title>
            <source>Ultraschall Med</source>
            <year>2008</year>
            <month>Oct</month>
            <volume>29</volume>
            <issue>5</issue>
            <fpage>499</fpage>
            <page-range>499-505</page-range>
            <pub-id pub-id-type="pmid">19241506</pub-id>
          </element-citation>
        </ref>
        <ref id="article-67758.r78">
          <label>78</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Battaglia</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Cervelli</surname>
                <given-names>R</given-names>
              </name>
            </person-group>
            <article-title>Liver investigations: Updating on US technique and contrast-enhanced ultrasound (CEUS).</article-title>
            <source>Eur J Radiol</source>
            <year>2017</year>
            <month>Nov</month>
            <volume>96</volume>
            <fpage>65</fpage>
            <page-range>65-73</page-range>
            <pub-id pub-id-type="pmid">29103478</pub-id>
          </element-citation>
        </ref>
        <ref id="article-67758.r79">
          <label>79</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Vijayaraghavan</surname>
                <given-names>GR</given-names>
              </name>
              <name>
                <surname>David</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Bermudez-Allende</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Sarwat</surname>
                <given-names>H</given-names>
              </name>
            </person-group>
            <article-title>Imaging-guided Parenchymal Liver Biopsy: How We Do It.</article-title>
            <source>J Clin Imaging Sci</source>
            <year>2011</year>
            <volume>1</volume>
            <fpage>30</fpage>
            <pub-id pub-id-type="pmid">21966627</pub-id>
          </element-citation>
        </ref>
        <ref id="article-67758.r80">
          <label>80</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Adnan</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Sheth</surname>
                <given-names>RA</given-names>
              </name>
            </person-group>
            <article-title>Image-guided Percutaneous Biopsy of the Liver.</article-title>
            <source>Tech Vasc Interv Radiol</source>
            <year>2021</year>
            <month>Dec</month>
            <volume>24</volume>
            <issue>4</issue>
            <fpage>100773</fpage>
            <pub-id pub-id-type="pmid">34895710</pub-id>
          </element-citation>
        </ref>
        <ref id="article-67758.r81">
          <label>81</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Smith</surname>
                <given-names>BC</given-names>
              </name>
              <name>
                <surname>Desmond</surname>
                <given-names>PV</given-names>
              </name>
            </person-group>
            <article-title>Outpatient liver biopsy using ultrasound guidance and the Biopty gun is safe and cost effective.</article-title>
            <source>Aust N Z J Med</source>
            <year>1995</year>
            <month>Jun</month>
            <volume>25</volume>
            <issue>3</issue>
            <fpage>209</fpage>
            <page-range>209-11</page-range>
            <pub-id pub-id-type="pmid">7487687</pub-id>
          </element-citation>
        </ref>
        <ref id="article-67758.r82">
          <label>82</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Shah</surname>
                <given-names>ND</given-names>
              </name>
              <name>
                <surname>Baron</surname>
                <given-names>TH</given-names>
              </name>
            </person-group>
            <article-title>Endoscopic ultrasound and the liver: current applications and beyond.</article-title>
            <source>J Hepatobiliary Pancreat Sci</source>
            <year>2018</year>
            <month>Mar</month>
            <volume>25</volume>
            <issue>3</issue>
            <fpage>171</fpage>
            <page-range>171-180</page-range>
            <pub-id pub-id-type="pmid">29334698</pub-id>
          </element-citation>
        </ref>
        <ref id="article-67758.r83">
          <label>83</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kennedy</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Wagner</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Cast&#x000e9;ra</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Hong</surname>
                <given-names>CW</given-names>
              </name>
              <name>
                <surname>Johnson</surname>
                <given-names>CL</given-names>
              </name>
              <name>
                <surname>Sirlin</surname>
                <given-names>CB</given-names>
              </name>
              <name>
                <surname>Taouli</surname>
                <given-names>B</given-names>
              </name>
            </person-group>
            <article-title>Quantitative Elastography Methods in Liver Disease: Current Evidence and Future Directions.</article-title>
            <source>Radiology</source>
            <year>2018</year>
            <month>Mar</month>
            <volume>286</volume>
            <issue>3</issue>
            <fpage>738</fpage>
            <page-range>738-763</page-range>
            <pub-id pub-id-type="pmid">29461949</pub-id>
          </element-citation>
        </ref>
        <ref id="article-67758.r84">
          <label>84</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Simonovsk&#x000fd;</surname>
                <given-names>V</given-names>
              </name>
            </person-group>
            <article-title>The diagnosis of cirrhosis by high resolution ultrasound of the liver surface.</article-title>
            <source>Br J Radiol</source>
            <year>1999</year>
            <month>Jan</month>
            <volume>72</volume>
            <issue>853</issue>
            <fpage>29</fpage>
            <page-range>29-34</page-range>
            <pub-id pub-id-type="pmid">10341686</pub-id>
          </element-citation>
        </ref>
        <ref id="article-67758.r85">
          <label>85</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Wernecke</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Henke</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Vassallo</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>von Bassewitz</surname>
                <given-names>DB</given-names>
              </name>
              <name>
                <surname>Diederich</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Peters</surname>
                <given-names>PE</given-names>
              </name>
              <name>
                <surname>Edel</surname>
                <given-names>G</given-names>
              </name>
            </person-group>
            <article-title>Pathologic explanation for hypoechoic halo seen on sonograms of malignant liver tumors: an in vitro correlative study.</article-title>
            <source>AJR Am J Roentgenol</source>
            <year>1992</year>
            <month>Nov</month>
            <volume>159</volume>
            <issue>5</issue>
            <fpage>1011</fpage>
            <page-range>1011-6</page-range>
            <pub-id pub-id-type="pmid">1329455</pub-id>
          </element-citation>
        </ref>
        <ref id="article-67758.r86">
          <label>86</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>D&#x00103;nil&#x00103;</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Popescu</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Sirli</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Sporea</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Martie</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Sendroiu</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>Contrast enhanced ultrasound (CEUS) in the evaluation of liver metastases.</article-title>
            <source>Med Ultrason</source>
            <year>2010</year>
            <month>Sep</month>
            <volume>12</volume>
            <issue>3</issue>
            <fpage>233</fpage>
            <page-range>233-7</page-range>
            <pub-id pub-id-type="pmid">21203602</pub-id>
          </element-citation>
        </ref>
        <ref id="article-67758.r87">
          <label>87</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Stange</surname>
                <given-names>BJ</given-names>
              </name>
              <name>
                <surname>Glanemann</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Nuessler</surname>
                <given-names>NC</given-names>
              </name>
              <name>
                <surname>Settmacher</surname>
                <given-names>U</given-names>
              </name>
              <name>
                <surname>Steinm&#x000fc;ller</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Neuhaus</surname>
                <given-names>P</given-names>
              </name>
            </person-group>
            <article-title>Hepatic artery thrombosis after adult liver transplantation.</article-title>
            <source>Liver Transpl</source>
            <year>2003</year>
            <month>Jun</month>
            <volume>9</volume>
            <issue>6</issue>
            <fpage>612</fpage>
            <page-range>612-20</page-range>
            <pub-id pub-id-type="pmid">12783404</pub-id>
          </element-citation>
        </ref>
        <ref id="article-67758.r88">
          <label>88</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Garc&#x000ed;a-Criado</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Gilabert</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Salmer&#x000f3;n</surname>
                <given-names>JM</given-names>
              </name>
              <name>
                <surname>Nicolau</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Vilana</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Bianchi</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Bu&#x000f1;esch</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Garc&#x000ed;a-Valdecasas</surname>
                <given-names>JC</given-names>
              </name>
              <name>
                <surname>Rimola</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Br&#x000fa;</surname>
                <given-names>C</given-names>
              </name>
            </person-group>
            <article-title>Significance of and contributing factors for a high resistive index on Doppler sonography of the hepatic artery immediately after surgery: prognostic implications for liver transplant recipients.</article-title>
            <source>AJR Am J Roentgenol</source>
            <year>2003</year>
            <month>Sep</month>
            <volume>181</volume>
            <issue>3</issue>
            <fpage>831</fpage>
            <page-range>831-8</page-range>
            <pub-id pub-id-type="pmid">12933490</pub-id>
          </element-citation>
        </ref>
        <ref id="article-67758.r89">
          <label>89</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Bajenaru</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Balaban</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>S&#x00103;vulescu</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Campeanu</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Patrascu</surname>
                <given-names>T</given-names>
              </name>
            </person-group>
            <article-title>Hepatic hemangioma -review-.</article-title>
            <source>J Med Life</source>
            <year>2015</year>
            <volume>8 Spec Issue</volume>
            <issue>Spec Issue</issue>
            <fpage>4</fpage>
            <page-range>4-11</page-range>
            <pub-id pub-id-type="pmid">26361504</pub-id>
          </element-citation>
        </ref>
        <ref id="article-67758.r90">
          <label>90</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Ito</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Tsujimoto</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Nakajima</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Igarashi</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Okamura</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Sakurai</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Nobuoka</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Otsubo</surname>
                <given-names>T</given-names>
              </name>
            </person-group>
            <article-title>Sonographic characterization of 271 hepatic hemangiomas with typical appearance on CT imaging.</article-title>
            <source>J Med Ultrason (2001)</source>
            <year>2012</year>
            <month>Apr</month>
            <volume>39</volume>
            <issue>2</issue>
            <fpage>61</fpage>
            <page-range>61-8</page-range>
            <pub-id pub-id-type="pmid">27278845</pub-id>
          </element-citation>
        </ref>
        <ref id="article-67758.r91">
          <label>91</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Park</surname>
                <given-names>SJ</given-names>
              </name>
              <name>
                <surname>Kim</surname>
                <given-names>JD</given-names>
              </name>
              <name>
                <surname>Seo</surname>
                <given-names>YS</given-names>
              </name>
              <name>
                <surname>Park</surname>
                <given-names>BJ</given-names>
              </name>
              <name>
                <surname>Kim</surname>
                <given-names>MJ</given-names>
              </name>
              <name>
                <surname>Um</surname>
                <given-names>SH</given-names>
              </name>
              <name>
                <surname>Kim</surname>
                <given-names>CH</given-names>
              </name>
              <name>
                <surname>Yim</surname>
                <given-names>HJ</given-names>
              </name>
              <name>
                <surname>Baik</surname>
                <given-names>SK</given-names>
              </name>
              <name>
                <surname>Jung</surname>
                <given-names>JY</given-names>
              </name>
              <name>
                <surname>Keum</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Jeen</surname>
                <given-names>YT</given-names>
              </name>
              <name>
                <surname>Lee</surname>
                <given-names>HS</given-names>
              </name>
              <name>
                <surname>Chun</surname>
                <given-names>HJ</given-names>
              </name>
              <name>
                <surname>Kim</surname>
                <given-names>CD</given-names>
              </name>
              <name>
                <surname>Ryu</surname>
                <given-names>HS</given-names>
              </name>
            </person-group>
            <article-title>Computed tomography findings for predicting severe acute hepatitis with prolonged cholestasis.</article-title>
            <source>World J Gastroenterol</source>
            <year>2013</year>
            <month>Apr</month>
            <day>28</day>
            <volume>19</volume>
            <issue>16</issue>
            <fpage>2543</fpage>
            <page-range>2543-9</page-range>
            <pub-id pub-id-type="pmid">23674857</pub-id>
          </element-citation>
        </ref>
        <ref id="article-67758.r92">
          <label>92</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Blechacz</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Gores</surname>
                <given-names>GJ</given-names>
              </name>
            </person-group>
            <article-title>Positron emission tomography scan for a hepatic mass.</article-title>
            <source>Hepatology</source>
            <year>2010</year>
            <month>Dec</month>
            <volume>52</volume>
            <issue>6</issue>
            <fpage>2186</fpage>
            <page-range>2186-91</page-range>
            <pub-id pub-id-type="pmid">20967825</pub-id>
          </element-citation>
        </ref>
        <ref id="article-67758.r93">
          <label>93</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Eo</surname>
                <given-names>JS</given-names>
              </name>
              <name>
                <surname>Paeng</surname>
                <given-names>JC</given-names>
              </name>
              <name>
                <surname>Lee</surname>
                <given-names>DS</given-names>
              </name>
            </person-group>
            <article-title>Nuclear imaging for functional evaluation and theragnosis in liver malignancy and transplantation.</article-title>
            <source>World J Gastroenterol</source>
            <year>2014</year>
            <month>May</month>
            <day>14</day>
            <volume>20</volume>
            <issue>18</issue>
            <fpage>5375</fpage>
            <page-range>5375-88</page-range>
            <pub-id pub-id-type="pmid">24833867</pub-id>
          </element-citation>
        </ref>
        <ref id="article-67758.r94">
          <label>94</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Price</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Patino</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Sahani</surname>
                <given-names>D</given-names>
              </name>
            </person-group>
            <article-title>Computed Tomography Angiography of the Hepatic, Pancreatic, and Splenic Circulation.</article-title>
            <source>Radiol Clin North Am</source>
            <year>2016</year>
            <month>Jan</month>
            <volume>54</volume>
            <issue>1</issue>
            <fpage>55</fpage>
            <page-range>55-70</page-range>
            <pub-id pub-id-type="pmid">26654391</pub-id>
          </element-citation>
        </ref>
        <ref id="article-67758.r95">
          <label>95</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Raoul</surname>
                <given-names>JL</given-names>
              </name>
              <name>
                <surname>Forner</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Bolondi</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Cheung</surname>
                <given-names>TT</given-names>
              </name>
              <name>
                <surname>Kloeckner</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>de Baere</surname>
                <given-names>T</given-names>
              </name>
            </person-group>
            <article-title>Updated use of TACE for hepatocellular carcinoma treatment: How and when to use it based on clinical evidence.</article-title>
            <source>Cancer Treat Rev</source>
            <year>2019</year>
            <month>Jan</month>
            <volume>72</volume>
            <fpage>28</fpage>
            <page-range>28-36</page-range>
            <pub-id pub-id-type="pmid">30447470</pub-id>
          </element-citation>
        </ref>
        <ref id="article-67758.r96">
          <label>96</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kruskal</surname>
                <given-names>JB</given-names>
              </name>
              <name>
                <surname>Newman</surname>
                <given-names>PA</given-names>
              </name>
              <name>
                <surname>Sammons</surname>
                <given-names>LG</given-names>
              </name>
              <name>
                <surname>Kane</surname>
                <given-names>RA</given-names>
              </name>
            </person-group>
            <article-title>Optimizing Doppler and color flow US: application to hepatic sonography.</article-title>
            <source>Radiographics</source>
            <year>2004</year>
            <season>May-Jun</season>
            <volume>24</volume>
            <issue>3</issue>
            <fpage>657</fpage>
            <page-range>657-75</page-range>
            <pub-id pub-id-type="pmid">15143220</pub-id>
          </element-citation>
        </ref>
        <ref id="article-67758.r97">
          <label>97</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Talwalkar</surname>
                <given-names>JA</given-names>
              </name>
              <name>
                <surname>Kurtz</surname>
                <given-names>DM</given-names>
              </name>
              <name>
                <surname>Schoenleber</surname>
                <given-names>SJ</given-names>
              </name>
              <name>
                <surname>West</surname>
                <given-names>CP</given-names>
              </name>
              <name>
                <surname>Montori</surname>
                <given-names>VM</given-names>
              </name>
            </person-group>
            <article-title>Ultrasound-based transient elastography for the detection of hepatic fibrosis: systematic review and meta-analysis.</article-title>
            <source>Clin Gastroenterol Hepatol</source>
            <year>2007</year>
            <month>Oct</month>
            <volume>5</volume>
            <issue>10</issue>
            <fpage>1214</fpage>
            <page-range>1214-20</page-range>
            <pub-id pub-id-type="pmid">17916549</pub-id>
          </element-citation>
        </ref>
        <ref id="article-67758.r98">
          <label>98</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Chernyak</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Fowler</surname>
                <given-names>KJ</given-names>
              </name>
              <name>
                <surname>Kamaya</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Kielar</surname>
                <given-names>AZ</given-names>
              </name>
              <name>
                <surname>Elsayes</surname>
                <given-names>KM</given-names>
              </name>
              <name>
                <surname>Bashir</surname>
                <given-names>MR</given-names>
              </name>
              <name>
                <surname>Kono</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Do</surname>
                <given-names>RK</given-names>
              </name>
              <name>
                <surname>Mitchell</surname>
                <given-names>DG</given-names>
              </name>
              <name>
                <surname>Singal</surname>
                <given-names>AG</given-names>
              </name>
              <name>
                <surname>Tang</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Sirlin</surname>
                <given-names>CB</given-names>
              </name>
            </person-group>
            <article-title>Liver Imaging Reporting and Data System (LI-RADS) Version 2018: Imaging of Hepatocellular Carcinoma in At-Risk Patients.</article-title>
            <source>Radiology</source>
            <year>2018</year>
            <month>Dec</month>
            <volume>289</volume>
            <issue>3</issue>
            <fpage>816</fpage>
            <page-range>816-830</page-range>
            <pub-id pub-id-type="pmid">30251931</pub-id>
          </element-citation>
        </ref>
      </ref-list>
    </back>
  </book-part>
</book-part-wrapper>
